array:21 [
  "pii" => "X2013251412002272"
  "issn" => "20132514"
  "doi" => "10.3265/Nefrologia.pre2012.Jul.11465"
  "estado" => "S300"
  "fechaPublicacion" => "2012-11-01"
  "documento" => "article"
  "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
  "subdocumento" => "fla"
  "cita" => "Nefrologia (English Version). 2012;32:782-9"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 5667
    "formatos" => array:3 [
      "EPUB" => 282
      "HTML" => 4696
      "PDF" => 689
    ]
  ]
  "Traduccion" => array:1 [
    "es" => array:17 [
      "pii" => "X0211699512002275"
      "issn" => "02116995"
      "doi" => "10.3265/Nefrologia.pre2012.Jul.11465"
      "estado" => "S300"
      "fechaPublicacion" => "2012-11-01"
      "documento" => "article"
      "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
      "subdocumento" => "fla"
      "cita" => "Nefrologia. 2012;32:782-9"
      "abierto" => array:3 [
        "ES" => true
        "ES2" => true
        "LATM" => true
      ]
      "gratuito" => true
      "lecturas" => array:2 [
        "total" => 7718
        "formatos" => array:3 [
          "EPUB" => 318
          "HTML" => 6769
          "PDF" => 631
        ]
      ]
      "es" => array:12 [
        "idiomaDefecto" => true
        "titulo" => "Efecto de la modalidad de diálisis y otros factores de prescripción sobre las pérdidas proteicas peritoneales en diálisis peritoneal"
        "tienePdf" => "es"
        "tieneTextoCompleto" => "es"
        "tieneResumen" => array:2 [
          0 => "es"
          1 => "en"
        ]
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "782"
            "paginaFinal" => "789"
          ]
        ]
        "titulosAlternativos" => array:1 [
          "en" => array:1 [
            "titulo" => "Effect of dialysis modality and other prescription factors on peritoneal protein excretion in peritoneal dialysis"
          ]
        ]
        "contieneResumen" => array:2 [
          "es" => true
          "en" => true
        ]
        "contieneTextoCompleto" => array:1 [
          "es" => true
        ]
        "contienePdf" => array:1 [
          "es" => true
        ]
        "resumenGrafico" => array:2 [
          "original" => 0
          "multimedia" => array:8 [
            "identificador" => "fig1"
            "etiqueta" => "Tab.  1"
            "tipo" => "MULTIMEDIAFIGURA"
            "mostrarFloat" => true
            "mostrarDisplay" => false
            "copyright" => "Elsevier España"
            "figura" => array:1 [
              0 => array:4 [
                "imagen" => "11465_19759_29134_es_11465_t1.jpg"
                "Alto" => 350
                "Ancho" => 600
                "Tamanyo" => 188045
              ]
            ]
            "descripcion" => array:1 [
              "es" => "Características generales de los grupos de estudio al inicio de diálisis peritoneal"
            ]
          ]
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "Ana Rodríguez-Carmona, Miguel Pérez Fontán, Miguel Pérez-Fontán, Sonia Pértega Díaz, Sonia Pértega-Díaz, Beatriz López Calviño, Beatriz López-Calviño, Andrés López Muñiz, Andrés López-Muñiz, Teresa García Falcón, Teresa García-Falcón"
            "autores" => array:11 [
              0 => array:2 [
                "nombre" => "Ana"
                "apellidos" => "Rodríguez-Carmona"
              ]
              1 => array:2 [
                "nombre" => "Miguel"
                "apellidos" => "Pérez Fontán"
              ]
              2 => array:2 [
                "nombre" => "Miguel"
                "apellidos" => "Pérez-Fontán"
              ]
              3 => array:2 [
                "nombre" => "Sonia"
                "apellidos" => "Pértega Díaz"
              ]
              4 => array:2 [
                "nombre" => "Sonia"
                "apellidos" => "Pértega-Díaz"
              ]
              5 => array:2 [
                "nombre" => "Beatriz"
                "apellidos" => "López Calviño"
              ]
              6 => array:2 [
                "nombre" => "Beatriz"
                "apellidos" => "López-Calviño"
              ]
              7 => array:2 [
                "nombre" => "Andrés"
                "apellidos" => "López Muñiz"
              ]
              8 => array:2 [
                "nombre" => "Andrés"
                "apellidos" => "López-Muñiz"
              ]
              9 => array:2 [
                "nombre" => "Teresa"
                "apellidos" => "García Falcón"
              ]
              10 => array:2 [
                "nombre" => "Teresa"
                "apellidos" => "García-Falcón"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "es"
      "Traduccion" => array:1 [
        "en" => array:9 [
          "pii" => "X2013251412002272"
          "doi" => "10.3265/Nefrologia.pre2012.Jul.11465"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => true
            "ES2" => true
            "LATM" => true
          ]
          "gratuito" => true
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "en"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251412002272?idApp=UINPBA000064"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699512002275?idApp=UINPBA000064"
      "url" => "/02116995/0000003200000006/v0_201502091338/X0211699512002275/v0_201502091339/es/main.assets"
    ]
  ]
  "itemSiguiente" => array:17 [
    "pii" => "X2013251412002264"
    "issn" => "20132514"
    "doi" => "10.3265/Nefrologia.pre2012.Jun.11242"
    "estado" => "S300"
    "fechaPublicacion" => "2012-11-01"
    "documento" => "article"
    "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
    "subdocumento" => "fla"
    "cita" => "Nefrologia (English Version). 2012;32:790-6"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 6654
      "formatos" => array:3 [
        "EPUB" => 295
        "HTML" => 5475
        "PDF" => 884
      ]
    ]
    "en" => array:12 [
      "idiomaDefecto" => true
      "titulo" => "The effect of pentoxifylline on reduction of proteinuria among patients with type 2 diabetes under blockade of angiotensin system: a double blind and randomized clinical trial"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "tieneResumen" => array:2 [
        0 => "es"
        1 => "en"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "790"
          "paginaFinal" => "796"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "El efecto de la pentoxifilina en la reducción de proteinuria en pacientes con diabetes tipo 2 con bloqueo del sistema de angiotensina: ensayo clínico doble ciego y aleatorizado"
        ]
      ]
      "contieneResumen" => array:2 [
        "es" => true
        "en" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:8 [
          "identificador" => "fig1"
          "etiqueta" => "Tab.  1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "copyright" => "Elsevier España"
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "11242_16025_23451_en_t111242.jpg"
              "Alto" => 639
              "Ancho" => 2180
              "Tamanyo" => 413272
            ]
          ]
          "descripcion" => array:1 [
            "en" => "Baseline demographic and clinical characteristics of patients"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Ali Ghorbani, Bita Omidvar, Seyed S. Beladi-Mousavi, Seyed Seifollah Beladi Mousavi, Elena Lak, Sima Vaziri"
          "autores" => array:10 [
            0 => array:2 [
              "nombre" => "Ali"
              "apellidos" => "Ghorbani"
            ]
            1 => array:2 [
              "nombre" => "Ali"
              "apellidos" => "Ghorbani"
            ]
            2 => array:2 [
              "nombre" => "Bita"
              "apellidos" => "Omidvar"
            ]
            3 => array:2 [
              "nombre" => "Bita"
              "apellidos" => "Omidvar"
            ]
            4 => array:2 [
              "nombre" => "Seyed S."
              "apellidos" => "Beladi-Mousavi"
            ]
            5 => array:2 [
              "nombre" => "Seyed Seifollah"
              "apellidos" => "Beladi Mousavi"
            ]
            6 => array:2 [
              "nombre" => "Elena"
              "apellidos" => "Lak"
            ]
            7 => array:2 [
              "nombre" => "Elena"
              "apellidos" => "Lak"
            ]
            8 => array:2 [
              "nombre" => "Sima"
              "apellidos" => "Vaziri"
            ]
            9 => array:2 [
              "nombre" => "Sima"
              "apellidos" => "Vaziri"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "X0211699512002267"
        "doi" => "10.3265/Nefrologia.pre2012.Jun.11242"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699512002267?idApp=UINPBA000064"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251412002264?idApp=UINPBA000064"
    "url" => "/20132514/0000003200000006/v0_201502091602/X2013251412002264/v0_201502091603/en/main.assets"
  ]
  "itemAnterior" => array:17 [
    "pii" => "X2013251412002280"
    "issn" => "20132514"
    "doi" => "10.3265/Nefrologia.pre2012.Jul.11483"
    "estado" => "S300"
    "fechaPublicacion" => "2012-11-01"
    "documento" => "article"
    "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
    "subdocumento" => "fla"
    "cita" => "Nefrologia (English Version). 2012;32:777-81"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 5838
      "formatos" => array:3 [
        "EPUB" => 290
        "HTML" => 4849
        "PDF" => 699
      ]
    ]
    "en" => array:12 [
      "idiomaDefecto" => true
      "titulo" => "Renal function assessment in non-steroidal anti-inflammatory drug prescriptions. A pilot study in a primary care centre"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "tieneResumen" => array:2 [
        0 => "es"
        1 => "en"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "777"
          "paginaFinal" => "781"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Uso de antiinflamatorios no esteroideos y monitorización de la función renal. Estudio piloto en un centro de salud de Atención Primaria"
        ]
      ]
      "contieneResumen" => array:2 [
        "es" => true
        "en" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:8 [
          "identificador" => "fig1"
          "etiqueta" => "Fig. 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "copyright" => "Elsevier España"
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "11483_16025_38431_en_f111483.jpg"
              "Alto" => 903
              "Ancho" => 2072
              "Tamanyo" => 313530
            ]
          ]
          "descripcion" => array:1 [
            "en" => "Relationship between new prescriptions and all prescriptions. Percentage of non-steroidal anti-inflammatory drug (NSAID) prescriptions out of the total of all prescriptions"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "ITZIAR DE PABLO LOPEZ DE ABECHUCO, Itziar De Pablo-López de Abechuco, M ANGELES GÁLVEZ MÚGICA, M. Ángeles Gálvez-Múgica, DANIEL RODRIGUEZ, Daniel Rodríguez, JOSE MANUEL DEL REY, J. Manuel Del Rey, ESTHER PRIETO, Esther Prieto, MIGUEL CUCHI, Miguel Cuchi, LUIS SANCHEZ PERUCA, Luis Sánchez-Peruca, FERNANDO Liaño García, Fernando Liaño-García"
          "autores" => array:16 [
            0 => array:2 [
              "nombre" => "ITZIAR"
              "apellidos" => "DE PABLO LOPEZ DE ABECHUCO"
            ]
            1 => array:2 [
              "nombre" => "Itziar"
              "apellidos" => "De Pablo-López de Abechuco"
            ]
            2 => array:2 [
              "nombre" => "M ANGELES"
              "apellidos" => "GÁLVEZ MÚGICA"
            ]
            3 => array:2 [
              "nombre" => "M. Ángeles"
              "apellidos" => "Gálvez-Múgica"
            ]
            4 => array:2 [
              "nombre" => "DANIEL"
              "apellidos" => "RODRIGUEZ"
            ]
            5 => array:2 [
              "nombre" => "Daniel"
              "apellidos" => "Rodríguez"
            ]
            6 => array:2 [
              "nombre" => "JOSE MANUEL"
              "apellidos" => "DEL REY"
            ]
            7 => array:2 [
              "nombre" => "J. Manuel"
              "apellidos" => "Del Rey"
            ]
            8 => array:2 [
              "nombre" => "ESTHER"
              "apellidos" => "PRIETO"
            ]
            9 => array:2 [
              "nombre" => "Esther"
              "apellidos" => "Prieto"
            ]
            10 => array:2 [
              "nombre" => "MIGUEL"
              "apellidos" => "CUCHI"
            ]
            11 => array:2 [
              "nombre" => "Miguel"
              "apellidos" => "Cuchi"
            ]
            12 => array:2 [
              "nombre" => "LUIS"
              "apellidos" => "SANCHEZ PERUCA"
            ]
            13 => array:2 [
              "nombre" => "Luis"
              "apellidos" => "Sánchez-Peruca"
            ]
            14 => array:2 [
              "nombre" => "FERNANDO"
              "apellidos" => "Liaño García"
            ]
            15 => array:2 [
              "nombre" => "Fernando"
              "apellidos" => "Liaño-García"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "X0211699512002283"
        "doi" => "10.3265/Nefrologia.pre2012.Jul.11483"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699512002283?idApp=UINPBA000064"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251412002280?idApp=UINPBA000064"
    "url" => "/20132514/0000003200000006/v0_201502091602/X2013251412002280/v0_201502091603/en/main.assets"
  ]
  "en" => array:14 [
    "idiomaDefecto" => true
    "titulo" => "Effect of dialysis modality and other prescription factors on peritoneal protein excretion in peritoneal dialysis"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "782"
        "paginaFinal" => "789"
      ]
    ]
    "autores" => array:1 [
      0 => array:3 [
        "autoresLista" => "Ana Rodríguez-Carmona, Miguel Pérez Fontán, Miguel Pérez-Fontán, Sonia Pértega Díaz, Sonia Pértega-Díaz, Beatriz López Calviño, Beatriz López-Calviño, Andrés López Muñiz, Andrés López-Muñiz, Teresa García Falcón, Teresa García-Falcón"
        "autores" => array:11 [
          0 => array:3 [
            "nombre" => "Ana"
            "apellidos" => "Rodríguez-Carmona"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "affa"
              ]
            ]
          ]
          1 => array:4 [
            "nombre" => "Miguel"
            "apellidos" => "P&#233;rez Font&#225;n"
            "email" => array:1 [
              0 => "miguel&#46;perez&#46;fontan&#64;sergas&#46;es"
            ]
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "affb"
              ]
            ]
          ]
          2 => array:4 [
            "nombre" => "Miguel"
            "apellidos" => "P&#233;rez-Font&#225;n"
            "email" => array:1 [
              0 => "miguel&#46;perez&#46;fontan&#64;sergas&#46;es"
            ]
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "affa"
              ]
            ]
          ]
          3 => array:3 [
            "nombre" => "Sonia"
            "apellidos" => "P&#233;rtega D&#237;az"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">c</span>"
                "identificador" => "affc"
              ]
            ]
          ]
          4 => array:3 [
            "nombre" => "Sonia"
            "apellidos" => "P&#233;rtega-D&#237;az"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">d</span>"
                "identificador" => "affd"
              ]
            ]
          ]
          5 => array:3 [
            "nombre" => "Beatriz"
            "apellidos" => "L&#243;pez Calvi&#241;o"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">c</span>"
                "identificador" => "affc"
              ]
            ]
          ]
          6 => array:3 [
            "nombre" => "Beatriz"
            "apellidos" => "L&#243;pez-Calvi&#241;o"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">d</span>"
                "identificador" => "affd"
              ]
            ]
          ]
          7 => array:3 [
            "nombre" => "Andr&#233;s"
            "apellidos" => "L&#243;pez Mu&#241;iz"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "affb"
              ]
            ]
          ]
          8 => array:3 [
            "nombre" => "Andr&#233;s"
            "apellidos" => "L&#243;pez-Mu&#241;iz"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "affa"
              ]
            ]
          ]
          9 => array:3 [
            "nombre" => "Teresa"
            "apellidos" => "Garc&#237;a Falc&#243;n"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "affb"
              ]
            ]
          ]
          10 => array:3 [
            "nombre" => "Teresa"
            "apellidos" => "Garc&#237;a-Falc&#243;n"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "affa"
              ]
            ]
          ]
        ]
        "afiliaciones" => array:4 [
          0 => array:3 [
            "entidad" => "Servicio de Nefrología, Complejo Hospitalario Universitario A Coruña,    "
            "etiqueta" => "<span class="elsevierStyleSup">a</span>"
            "identificador" => "affa"
          ]
          1 => array:3 [
            "entidad" => "Nefrología, Complejo Hospitalario Universitario A Coruña, A Coruña, A Coruña, Spain, "
            "etiqueta" => "<span class="elsevierStyleSup">b</span>"
            "identificador" => "affb"
          ]
          2 => array:3 [
            "entidad" => "Epidemiología, Complejo Hospitalario Universitario A Coruña, A Coruña, A Coruña, Spain, "
            "etiqueta" => "<span class="elsevierStyleSup">c</span>"
            "identificador" => "affc"
          ]
          3 => array:3 [
            "entidad" => "Servicio de Epidemiología, Complejo Hospitalario Universitario A Coruña,    "
            "etiqueta" => "<span class="elsevierStyleSup">d</span>"
            "identificador" => "affd"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "es" => array:1 [
        "titulo" => "Efecto de la modalidad de di&#225;lisis y otros factores de prescripci&#243;n sobre las p&#233;rdidas proteicas peritoneales en di&#225;lisis peritoneal"
      ]
    ]
    "resumenGrafico" => array:2 [
      "original" => 0
      "multimedia" => array:8 [
        "identificador" => "fig1"
        "etiqueta" => "Tab.  3"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "copyright" => "Elsevier Espa&#241;a"
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "11465_16025_29133_en_t311465.jpg"
            "Alto" => 937
            "Ancho" => 2183
            "Tamanyo" => 872635
          ]
        ]
        "descripcion" => array:1 [
          "en" => "Univariate correlations between treatment prescription and optimisation and 24-hour peritoneal equilibrium test"
        ]
      ]
    ]
    "textoCompleto" => "<p class="elsevierStylePara"><span class="elsevierStyleBold">INTRODUCTION</span></p><p class="elsevierStylePara">&#160;</p><p class="elsevierStylePara">Peritoneal protein excretion &#40;PPE&#41; is an undesired consequence of peritoneal dialysis &#40;PD&#41; that contributes to a varying degree to malnutrition<span class="elsevierStyleSup">1</span> and other complications inherent to this technique&#46;<span class="elsevierStyleSup">2-4</span> Scarce information is available regarding the factors that affect the magnitude of PPE in daily clinical practice&#44; apart from the expected correlation with general peritoneal transport characteristics&#46;<span class="elsevierStyleSup">5-8</span> It is unclear what sort of effect the conditions of the dialysis prescription&#44; and the modality of PD in particular&#44; have on this parameter&#46; Previous attempts to clarify this issue have been limited by the notable disparities between the populations compared&#46; The type of peritoneal transport will also influence the prescription provided&#44; including the decision between continuous ambulatory peritoneal dialysis &#40;CAPD&#41; or automated peritoneal dialysis &#40;APD&#41;&#46; Stratified multivariate analysis techniques aid in adjusting for these variables&#44; but the use of peritoneal creatinine transport for this purpose is inadequate&#44; since this variable provides little predictive value for peritoneal protein transport&#46;<span class="elsevierStyleSup">9&#44;10</span></p><p class="elsevierStylePara">We present the results of an observational study involving a large cohort of incident patients on PD&#44; with the primary objective of establishing the influence of prescription characteristics &#40;including modality of PD&#41; on PPE during a 24-hour period&#44; taking advantage of the standardised measurements of peritoneal protein transport taken during serial peritoneal equilibrium tests &#40;PET&#41;&#46;</p><p class="elsevierStylePara">&#160;</p><p class="elsevierStylePara"><span class="elsevierStyleBold">POPULATION AND METHOD</span></p><p class="elsevierStylePara">&#160;</p><p class="elsevierStylePara"><span class="elsevierStyleBold">Study design</span></p><p class="elsevierStylePara">&#160;</p><p class="elsevierStylePara">Ours was a prospective and observational study examining a cohort of incident patients on PD treated at our hospital between January 2000 and June 2010&#46; The inclusion criteria used were&#58; minimum of two months on dialysis treatment with no registered cases of peritonitis and availability of initial 24-hour PPE measurements and during the first PET&#46; The primary study variable was the magnitude of PPE in PD effluent during a 24-hour period&#46; The primary adjustment variable was an estimate of peritoneal protein transport during a standard PET using a 2&#46;27&#37; glucose solution&#46; We also examined standard demographic&#44; clinical&#44; and laboratory parameters in order to obtain adjusted estimates&#46;</p><p class="elsevierStylePara">At our hospital&#44; traditional PD solutions were used until May 2008&#46; After this point&#44; all patients were treated using solutions with low concentrations of glucose degradation products&#46;</p><p class="elsevierStylePara">The study protocol was in accordance with the ethical criteria required for observational studies at our hospital as well as the Helsinki Declaration&#46;</p><p class="elsevierStylePara">&#160;</p><p class="elsevierStylePara"><span class="elsevierStyleBold">Laboratory methods and secondary calculations</span></p><p class="elsevierStylePara">&#160;</p><p class="elsevierStylePara">Blood levels of haemoglobin&#44; glucose&#44; urea&#44; creatinine&#44; albumin&#44; and cholesterol were estimated using a standard auto-analyser&#46; Glucose and creatinine levels in the dialysate fluid and urea and creatinine levels in urine samples were measured using procedures specifically designed for the same auto-analyser&#46; Plasma C-reactive protein &#40;CRP&#41; was measured using an immunoturbidimetric test &#40;Roche Diag&#46;&#44; Mannheim&#44; Germany&#41;&#46; We also used a modified colorimetric test &#40;pirogalol red&#41; to measure total protein content of urine samples and peritoneal effluent&#46; In a previous study&#44;<span class="elsevierStyleSup">10</span> we showed this to be an appropriate technique that is not affected by sample storage or by high concentrations of glucose present in the dialysate&#46;</p><p class="elsevierStylePara">We used universally accepted procedures for performing PET&#46; Glomerular filtration rate was estimated as the mean 24-hour clearance rates of urea and creatinine&#46; Mean daily ultrafiltration rate &#40;UF&#41; and blood pressure were compiled from the registries of daily values recorded by the patients themselves&#46;</p><p class="elsevierStylePara">&#160;</p><p class="elsevierStylePara"><span class="elsevierStyleBold">Strategy of analysis </span></p><p class="elsevierStylePara">&#160;</p><p class="elsevierStylePara">We compared the temporal progression of 24-hour PPE between patients treated with CAPD and those treated with APD until the end of the second year of follow-up&#44; using both strategies of intention to treat and final treatment&#46; Results were similar under both approaches&#44; and the results presented in this article are derived from final treatment strategies&#46; We also monitored longitudinal differences in demographic and clinical parameters&#44; peritoneal function&#44; prescription&#44; and optimisation of treatment&#44; searching for univariate correlations with 24-hour PPE&#46; However&#44; our primary objective was to analyse how the conditions of peritoneal dialysis prescriptions affected the primary study variable&#44; taking into account possible temporal variation in PPE and the change produced to the PD prescription &#40;including the modality of dialysis&#41; during the follow-up period&#46;</p><p class="elsevierStylePara">&#160;</p><p class="elsevierStylePara"><span class="elsevierStyleBold">Statistical analysis</span></p><p class="elsevierStylePara">&#160;</p><p class="elsevierStylePara">Numerical variables are presented as mean &#177; standard deviation or median and range&#44; as appropriate&#46; Univariate comparisons were performed using Student&#8217;s t-test&#44; ANOVA&#44; and Mann-Whitney and Wilcoxon tests &#40;numerical variables&#41; and chi-square distribution &#40;categorical variables&#41;&#46; We also calculated correlations between numerical variables using Spearman&#8217;s test&#46; We used a generalised linear model with repeated measures to analyse univariate tendencies over time&#44; both for 24-hour PPE and for PPE during serial PETs&#46;</p><p class="elsevierStylePara">We also performed a multivariate analysis using multi-level mixed linear models&#44; selecting variables using forwards stepwise selection&#46; The effect of patient heterogeneity was adjusted for as a random effect&#44; while the covariates analysed were adjusted for as fixed effects&#46; Serial measurements of PPE during PET&#44; which represented the individual characteristics of peritoneal protein transport over time&#44; were included systematically in all models tested&#46; We also analysed the potential effects of cardiovascular events &#40;only those that required hospitalisation&#41; and peritonitis during the follow-up period&#44; as well as for the potential effects of treatment with angiotensin-converting enzyme &#40;ACE&#41; inhibitors and angiotensin receptor blockers &#40;ARB&#41; on the progression of PPE over time&#46; Associations between the study variables and PPE were estimated using beta coefficients &#40;with 95&#37; confidence intervals &#91;CI&#93;&#41; in the fixed effects section of the statistical models&#46; We also analysed interaction terms&#46; Finally&#44; we used Bayesian &#40;BIC&#41; and Akaike&#8217;s information criteria &#40;AIC&#41; to compare maximum likelihood models&#46;</p><p class="elsevierStylePara">We used SPSS &#40;v&#46;18&#46;0&#41; and Stat &#40;v&#46;11&#41; statistical software for all statistical analyses&#46;</p><p class="elsevierStylePara">&#160;</p><p class="elsevierStylePara"><span class="elsevierStyleBold">RESULTS</span></p><p class="elsevierStylePara">&#160;</p><p class="elsevierStylePara">Of the 313 patients evaluated&#44; 284 complied with the study inclusion criteria&#46; Table 1 summarises the general characteristics of the study population at the start of PD&#46; Fifteen patients &#40;5&#46;3&#37;&#41; suffered at least one cardiovascular event during the first 6 months&#44; 24 &#40;8&#46;5&#37;&#41; between months 6 and 12&#44; and 49 &#40;17&#46;3&#37;&#41; during the second year of the follow-up regimen&#46; The cumulative incidences of peritonitis were 59 &#40;20&#46;8&#37;&#41;&#44; 45 &#40;15&#46;8&#37;&#41;&#44; and 26 &#40;9&#46;2&#37;&#41;&#44; respectively&#46; Table 2 demonstrates the parameters for prescription and treatment optimisation compiled during the follow-up period&#46; Only two patients had dry-day regimens at the start of PD&#44; and four others were prescribed dry days at some other point during follow-up&#46; The majority of the differences observed were expected&#44; but surprisingly&#44; PPE during serial PETs was consistently higher in patients on CAPD&#44; while small solute transport &#40;P&#47;D creatinine at 4 hours &#91;P&#47;D<span class="elsevierStyleInf">crea</span>&#93;&#41; was higher in patients treated with APD&#44; although this difference was only significant in baseline measurements &#40;Table 2&#41;&#46;</p><p class="elsevierStylePara">Changes in the type of PD administered were relatively common&#44; and involved switching from CAPD to APD in 43 cases and switching from APD to CAPD in 4&#46; Table 3 shows the primary univariate correlations between 24-hour PPE and variables of treatment optimisation and prescription&#46; The primary study variable was also significantly correlated with baseline Charlson comorbidity index &#40;r&#61;0&#46;16&#59; <span class="elsevierStyleItalic">P</span>&#61;&#46;006&#41; and CRP &#40;r&#61;0&#46;15&#59; <span class="elsevierStyleItalic">P</span>&#61;&#46;014&#41;&#46; Univariate analyses based on intention to treat and based on final treatment &#40;Table 2&#44; Figure 1&#41; tended towards higher 24-hour PPE in patients on CAPD&#44; although the difference only reached statistical significance after 24 months&#46; On the other hand&#44; univariate analyses with repeated measures showed no significant long-term changes for PPE during PET or in a 24-hour period&#44; neither in the overall group nor based on modality of PD or the presence&#47;absence of peritonitis during the first year of follow-up&#46;</p><p class="elsevierStylePara">The multi-level mixed models &#40;Table 4&#41; identified CAPD &#40;vs&#46; APD&#41;&#44; total volume infused in 24 hours&#44; and daily UF as independent predictors of 24-hour PPE&#44; after adjusting for standardised peritoneal protein transport &#40;PPT&#41;&#46; Total volume drained acted in the models as a surrogate for infused volume and UF &#40;B&#61;297&#46;9&#59; 95&#37; CI&#58; 203&#46;6&#47;292&#46;3&#59; <span class="elsevierStyleItalic">P</span>&#60;&#46;0005&#41;&#46; All variables included in the final model had a significant impact on both AIC and BIC with the exception of daily UF&#44; suggesting that this variable has little practical influence on 24-hour PPE&#46; We detected no significant interaction terms between the variables in the final model except for a minor interaction between PPE during PET and total volume infused &#40;B&#61;-0&#46;18&#59; 95&#37; CI&#58; -0&#46;6&#47;-0&#46;01&#59; <span class="elsevierStyleItalic">P</span>&#61;&#46;039&#41;&#44; which we ignored in order to give greater clarity to the presentation of our results&#46; No other variables related to clinical results&#44; optimisation of treatment&#44; or prescription &#40;Table 3&#41; were independently correlated with 24-hour PPE&#46; In particular&#44; cardiovascular events &#40;B&#61;-149&#46;9&#59; 95&#37; CI&#58; -969&#46;5&#47;669&#46;7&#59; <span class="elsevierStyleItalic">P</span>&#61;&#46;72&#41;&#44; peritonitis &#40;B&#61;389&#46;0&#59; 95&#37; CI&#58; -117&#46;6&#47;895&#46;7&#59; <span class="elsevierStyleItalic">P</span>&#61;&#46;13&#41;&#44; and treatment with ACE&#47;ARB &#40;B&#61;-17&#46;6&#59; 95&#37; CI&#58; 443&#46;2&#47;407&#46;9&#59; <span class="elsevierStyleItalic">P</span>&#61;&#46;94&#41; all failed to show a time-dependent correlation with 24-hour PPE&#46;</p><p class="elsevierStylePara">The multivariate analysis showed tendencies towards decreased PPE during follow-up&#44; although this effect only reached statistical significance after 12 months &#40;Table 4&#41;&#46; We performed a stratified statistical analysis in order to rule out the possibility that this effect might be the consequence of an earlier exit from PD in patients with a greater rate of 24-hour PPE&#46; The analysis showed slight and non-significant tendencies towards increased rates of late exit from PD &#40;24 months&#41; in patients in the first and fourth quartile of PPE results taken during PET&#46;</p><p class="elsevierStylePara">&#160;</p><p class="elsevierStylePara"><span class="elsevierStyleBold">DISCUSSION</span></p><p class="elsevierStylePara">&#160;</p><p class="elsevierStylePara">PPE is correlated with general characteristics of peritoneal transport in each individual&#46; However&#44; the use of estimators of small solute transport as a marker for proteins is quite unreliable&#44; since despite the fact that the correlation between PPE and P&#47;D<span class="elsevierStyleInf">crea</span> is statistically significant&#44; it is far from being unequivocal&#46;<span class="elsevierStyleSup">9&#44;10</span> This limitation is logical&#44; given the fact that different pathways are used for peritoneal transport of proteins and of small solutes&#46;<span class="elsevierStyleSup">11</span> If we wish to perform an adjusted evaluation of the effect of other factors on 24-hour PPE&#44; there is no specific marker available for the characteristics of peritoneal protein transport&#46; In previous studies&#44; we showed that a standardised estimate of protein transport during PET is useful for this objective&#46;<span class="elsevierStyleSup">10&#44;12</span></p><p class="elsevierStylePara">Several studies have explored the possibility of using common demographic and clinical markers of peritoneal protein transport in patients on PD&#46; Advanced age&#44; diabetes&#44; cardiovascular comorbidity factors&#44; obesity&#47;overweight&#44; residual renal function&#44; proteinuria&#44; and plasma CRP are some of the most frequently cited factors&#46;<span class="elsevierStyleSup">8-14 A</span> comprehensive evaluation suggests that PPE is associated with cardiovascular disease&#44; supporting the hypothesis that this serves as a marker for large peritoneal pore disorders&#44; and indirectly&#44; for endothelial dysfunction&#46;<span class="elsevierStyleSup">15&#44;16</span> In fact&#44; some studies have demonstrated an association between PPE at the start of PD and mortality while on PD&#46;<span class="elsevierStyleSup">9&#44;12</span> In our study&#44; we observed a univariate association between PPE and Charlson comorbidity index and plasma CRP&#44; although the correlation disappears after adjusting for peritoneal protein transport during PET&#46;</p><p class="elsevierStylePara">Very few studies have examined the influence of the conditions of the PD prescription on 24-hour PPE&#46; Kathuria et al&#46;<span class="elsevierStyleSup">5</span> compared PPE in patients treated with CAPD and nocturnal intermittent PD &#40;NIPD&#41;&#44; observing no consistent differences between the two modalities&#44; even after stratifying patients based on peritoneal transport of small molecules &#40;P&#47;D<span class="elsevierStyleInf">crea</span>&#41;&#46; On the other hand&#44; Heaf et al&#46;<span class="elsevierStyleSup">15</span> observed lower PPE values during NIPD than in patients on APD with wet day&#46; In a smaller study&#44; Westra et al&#46;<span class="elsevierStyleSup">17</span> observed relatively high levels of PPE in nine patients treated with APD&#46; Both an increase in the number of cycles administered and a longer duration of treatment appear to be associated with higher PPE&#46;<span class="elsevierStyleSup">17</span> However&#44; the design of this study&#44; which lacked a control group on CAPD&#44; does not allow for drawing clear conclusions based on these results&#46;</p><p class="elsevierStylePara">In our study&#44; patients on CAPD had different peritoneal protein transport characteristics &#40;estimated during serial PETs&#41; than patients on APD &#40;Table 2&#41;&#46; This difference alone could explain why the simple analysis of 24-hour PPE showed the tendency for higher levels in patients on CAPD than in those on APD &#40;Table 2&#41;&#46; On the other hand&#44; the univariate tests for repeated measures detected a notable stability in PPE during PET and as measured over 24 hours&#44; which is in agreement with the results from previous studies&#46;<span class="elsevierStyleSup">8</span> The multi-level mixed models &#40;Table 4&#41; showed that the conditions of the prescription of PD can also influence 24-hour PPE&#46; Both total infusion volume and daily UF were directly and independently correlated with the primary study variable&#46; UF can be considered as a simple complementary metric to infused volume&#44; but the possibility of a specific effect of this variable on peritoneal protein transport is a controversial subject&#46; Recent authors have shown a direct correlation between these two variables&#44;<span class="elsevierStyleSup">8&#44;10</span> whereas a previous study by Waniewski et al&#46;<span class="elsevierStyleSup">18</span> showed that UF can be directly and inversely correlated with PPE&#44; depending on the category of peritoneal transport that the patient falls under&#44; with practically neutral effects when analysing the total population treated with PD&#46; The lack of a significant impact of UF on AIC and BIC in the multivariate analysis suggests scarce clinical relevance for this variable&#46;</p><p class="elsevierStylePara">The use of CAPD was associated with higher 24-hour PPE values than APD&#44; after adjusting for the characteristics of peritoneal protein transport &#40;PET&#41; and total volume infused&#46; The significance of this finding is unclear&#44; and we cannot rule out that it is the product of a residual bias derived from an incomplete adjustment for other factors in the analysis&#46; The use of APD&#44; based on shorter and more frequent cycles&#44; could be the cause of slightly but significantly lower PPE values&#44; given the accumulation of infusion and drainage times&#46; The impact of this factor should not be so important if we assume that peritoneal protein transport is linear during exchanges&#44; in contrast to the pattern of small solute transport&#46;<span class="elsevierStyleSup">19 </span>We should also point out that other studies have suggested that peritoneal protein excretion could be faster during the first hour of dialysis<span class="elsevierStyleSup">18</span> and then assume a linear pattern as the session progresses&#46; If this were true&#44; we might even expect greater PPE in the short exchanges typical of APD&#46; However&#44; this phenomenon is probably the result of both the mixture of residual volume&#44; which is rich in proteins&#44; with the recently infused dialysate&#44; and the phenomenon of proteins being drawn from the interstitial space into the peritoneal cavity during the early stage of each exchange&#46; Either of these effects could be relevant during long-duration dialysis sessions &#40;such as those performed in CAPD&#41;&#44; but only during the first of a series of short exchanges &#40;such as in APD&#41;&#46;</p><p class="elsevierStylePara">Our study did involve certain limitations&#44; including a non-randomised assignment of patients to the different modalities of PD&#46; In addition&#44; a portion of our study patients switched PD modalities during the follow-up period&#44; mostly from CAPD to APD&#44; and membrane dysfunction could prompt some of these changes&#46; The multivariate strategy and time-dependent statistical analysis were designed to compensate for these potential biases&#46; In addition&#44; our hospital does not routinely administer NIPD&#44; which impedes our ability to draw valid conclusions with respect to this modality of APD&#46; Finally&#44; the majority of patients were treated using traditional PD solutions&#46; However&#44; a recent short-term study at our hospital demonstrated similar PPE rates in patients treated with traditional or biocompatible solutions&#46;<span class="elsevierStyleSup">20</span> Our study also presents qualities that provide substantial robustness to our conclusions&#46; First&#44; the study population was quite large&#44; allowing for drawing conclusions based on significant results&#46; The available clinical information was also quite complete&#44; and the study design allowed for both cross-sectional and longitudinal comparisons&#46; Finally&#44; the availability of standardised estimates of peritoneal protein transport in serial PETs allowed for the use of this variable in order to adjust for the expected heterogeneity among individual characteristics of peritoneal transport&#44; particularly when comparing between patients on CAPD and those on APD&#46;</p><p class="elsevierStylePara">To conclude&#44; the individual characteristics of peritoneal protein transport represent a basic determining factor for 24-hour PPE in patients on PD&#44; but the conditions of the dialysis prescription also can influence this variable&#46; The CAPD modality is associated with greater PPE than APD&#44; although this difference is compensated by the direct association between PPE and total volume infused &#40;which tends to be greater in CAPD&#41;&#46; Daily UF and time on PD were secondary independent markers of PPE in patients on PD&#46;</p><p class="elsevierStylePara">&#160;</p><p class="elsevierStylePara"><span class="elsevierStyleBold">Conflicts of interest</span></p><p class="elsevierStylePara">&#160;</p><p class="elsevierStylePara">The authors declare that they have no potential conflicts of interest related to the contents of this article&#46;</p><p class="elsevierStylePara"><a href="grande&#47;11465&#95;16025&#95;29133&#95;en&#95;t311465&#46;jpg" class="elsevierStyleCrossRefs"><img src="11465_16025_29133_en_t311465.jpg" alt="Univariate correlations between treatment prescription and optimisation and 24-hour peritoneal equilibrium test"></img></a></p><p class="elsevierStylePara">Table 3&#46; Univariate correlations between treatment prescription and optimisation and 24-hour peritoneal equilibrium test</p><p class="elsevierStylePara"><a href="grande&#47;11465&#95;16025&#95;38388&#95;en&#95;t111465&#46;jpg" class="elsevierStyleCrossRefs"><img src="11465_16025_38388_en_t111465.jpg" alt="General characteristics of the study groups at the start of peritoneal dialysis"></img></a></p><p class="elsevierStylePara">Table 1&#46; General characteristics of the study groups at the start of peritoneal dialysis</p><p class="elsevierStylePara"><a href="grande&#47;11465&#95;16025&#95;38389&#95;en&#95;t211465&#46;jpg" class="elsevierStyleCrossRefs"><img src="11465_16025_38389_en_t211465.jpg" alt="Variables for treatment prescription and optimisation"></img></a></p><p class="elsevierStylePara">Table 2&#46; Variables for treatment prescription and optimisation</p><p class="elsevierStylePara"><a href="grande&#47;11465&#95;16025&#95;38391&#95;en&#95;t411465&#46;jpg" class="elsevierStyleCrossRefs"><img src="11465_16025_38391_en_t411465.jpg" alt="Predictors for 24-hour peritoneal protein excretion&#46; Multi-level mixed model&#46; Best model"></img></a></p><p class="elsevierStylePara">Table 4&#46; Predictors for 24-hour peritoneal protein excretion&#46; Multi-level mixed model&#46; Best model</p><p class="elsevierStylePara"><a href="grande&#47;11465&#95;16025&#95;38392&#95;en&#95;f111465&#46;jpg" class="elsevierStyleCrossRefs"><img src="11465_16025_38392_en_f111465.jpg" alt="Peritoneal protein excretion in 24 hours in patients treated with continuous ambulatory peritoneal dialysis or automated peritoneal dialysis during the follow-up period &#40;according to treatment type&#41;"></img></a></p><p class="elsevierStylePara">Figure 1&#46; Peritoneal protein excretion in 24 hours in patients treated with continuous ambulatory peritoneal dialysis or automated peritoneal dialysis during the follow-up period &#40;according to treatment type&#41;</p>"
    "pdfFichero" => "P1-E544-S3760-A11465-EN.pdf"
    "tienePdf" => true
    "PalabrasClave" => array:2 [
      "es" => array:5 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Palabras clave"
          "identificador" => "xpalclavsec437077"
          "palabras" => array:1 [
            0 => "Di&#225;lisis peritoneal autom&#225;tica"
          ]
        ]
        1 => array:4 [
          "clase" => "keyword"
          "titulo" => "Palabras clave"
          "identificador" => "xpalclavsec437079"
          "palabras" => array:1 [
            0 => "Prescripci&#243;n"
          ]
        ]
        2 => array:4 [
          "clase" => "keyword"
          "titulo" => "Palabras clave"
          "identificador" => "xpalclavsec437081"
          "palabras" => array:1 [
            0 => "Prueba de equilibrio peritoneal"
          ]
        ]
        3 => array:4 [
          "clase" => "keyword"
          "titulo" => "Palabras clave"
          "identificador" => "xpalclavsec437083"
          "palabras" => array:1 [
            0 => "Prote&#237;na"
          ]
        ]
        4 => array:4 [
          "clase" => "keyword"
          "titulo" => "Palabras clave"
          "identificador" => "xpalclavsec437085"
          "palabras" => array:1 [
            0 => "DPCA"
          ]
        ]
      ]
      "en" => array:5 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Keywords"
          "identificador" => "xpalclavsec437078"
          "palabras" => array:1 [
            0 => "Automated PD"
          ]
        ]
        1 => array:4 [
          "clase" => "keyword"
          "titulo" => "Keywords"
          "identificador" => "xpalclavsec437080"
          "palabras" => array:1 [
            0 => "Prescription"
          ]
        ]
        2 => array:4 [
          "clase" => "keyword"
          "titulo" => "Keywords"
          "identificador" => "xpalclavsec437082"
          "palabras" => array:1 [
            0 => "Peritoneal equilibration test"
          ]
        ]
        3 => array:4 [
          "clase" => "keyword"
          "titulo" => "Keywords"
          "identificador" => "xpalclavsec437084"
          "palabras" => array:1 [
            0 => "Protein"
          ]
        ]
        4 => array:4 [
          "clase" => "keyword"
          "titulo" => "Keywords"
          "identificador" => "xpalclavsec437086"
          "palabras" => array:1 [
            0 => "CAPD"
          ]
        ]
      ]
    ]
    "tieneResumen" => true
    "resumen" => array:2 [
      "es" => array:1 [
        "resumen" => "<p class="elsevierStylePara"><span class="elsevierStyleBold">Antecedentes</span><span class="elsevierStyleBold">&#58;</span> Existe informaci&#243;n insuficiente sobre los factores que influyen en las p&#233;rdidas proteicas peritoneales &#40;PPP&#41; durante el tratamiento con di&#225;lisis peritoneal &#40;DP&#41;&#46; En particular&#44; se desconoce el efecto que la modalidad de DP y otras condiciones de prescripci&#243;n pueden tener sobre esta variable&#46; <span class="elsevierStyleBold">M&#233;todo</span><span class="elsevierStyleBold">&#58;</span> Siguiendo un dise&#241;o prospectivo y observacional&#44; analizamos el efecto de las condiciones de prescripci&#243;n de DP sobre las PPP en 24 horas &#40;variable principal&#41; en una cohorte de pacientes incidentes en DP&#46; La estrategia de an&#225;lisis incluy&#243; an&#225;lisis estad&#237;stico mediante modelos mixtos multinivel y estimaciones estandarizadas del transporte proteico peritoneal durante pruebas de equilibrio peritoneal seriadas&#44; con el fin de ajustar para desigualdades en las caracter&#237;sticas de las poblaciones manejadas con diferentes pautas de prescripci&#243;n&#46; <span class="elsevierStyleBold">Resultados</span><span class="elsevierStyleBold">&#58;</span> Estudiamos 284 pacientes&#44; 197 en DP continua ambulatoria &#40;DPCA&#41; y 87 en DP autom&#225;tica &#40;DPA&#41; al inicio de seguimiento&#46; Ambos grupos mostraron diferencias significativas en sus caracter&#237;sticas cl&#237;nicas y de funci&#243;n peritoneal&#46; Las estimaciones seriadas de las PP de 24 horas mostraron valores marginalmente m&#225;s altos en DPCA&#44; permaneciendo esencialmente estables durante el seguimiento&#46; El an&#225;lisis multivariante identific&#243; a la DPCA &#40;B &#61; 888&#44;5 mg&#44; intervalo de confianza 95&#37;&#58; 327&#44;5&#47;1448&#44;6&#41;&#44; el volumen total de dializado infundido &#40;B &#61; 275&#44;9 mg&#47;l&#44; 153&#44;9&#47;397&#44;9&#41; y la ultrafiltraci&#243;n diaria &#40;B &#61; 0&#44;41 mg&#47;ml&#44; 0&#44;02&#47;0&#44;80&#41; como predictores independientes de las PPP de 24 horas&#46; El modelo tambi&#233;n mostr&#243; tendencia a disminuci&#243;n en las PPP con el tiempo en DP&#46; <span class="elsevierStyleBold">Conclusiones</span><span class="elsevierStyleBold">&#58;</span> Las caracter&#237;sticas individuales de transporte peritoneal de prote&#237;nas son el principal determinante de las PPP en 24 horas&#46; La pauta de cambios largos &#40;DPCA&#41; asocia mayores PPP que la de cambios cortos &#40;DPA&#41;&#44; aunque esta diferencia se compensa en la pr&#225;ctica por la correlaci&#243;n positiva entre PPP y volumen infundido&#46; Ultrafiltraci&#243;n y tiempo en di&#225;lisis son predictores secundarios de PPP en 24 horas&#46;</p>"
      ]
      "en" => array:1 [
        "resumen" => "<p class="elsevierStylePara"><span class="elsevierStyleBold">Background&#58;</span> There is a deficit of information regarding the factors that influence peritoneal protein excretion &#40;PPE&#41; during PD therapy&#46; In particular&#44; the effects of the modality of PD and other conditions of the dialysis prescription remain unclear&#46; <span class="elsevierStyleBold">Method&#58;</span> This prospective&#44; observational study analysed the effects of prescription characteristics on 24-hour PPE &#40;study variable&#41; in a cohort of patients starting PD&#46; Our statistical analysis included a multi-level mixed model and standardised estimations of peritoneal protein transport during serial four-hour peritoneal equilibrium tests in order to control for disparities in the characteristics of patients managed on different regimens&#46; <span class="elsevierStyleBold">Results&#58;</span> We evaluated 284 patients&#44; 197 on CAPD and 87 on automated PD &#40;APD&#41;&#44; at the start of PD treatment&#46; The two groups differed in terms of clinical characteristics and peritoneal function&#46; Univariate&#44; serial estimates of 24-hour PPE were marginally higher in CAPD patients&#44; and remained essentially stable over time in both groups&#46; Multivariate analyses identified CAPD &#40;B&#61;888&#46;5mg&#44; 95&#37; CI&#58; 327&#46;5&#47;1448&#46;6&#41;&#44; total dialysate volume infused per day &#40;B&#61;275&#46;9mg&#47;Ll&#59; 153&#46;9&#47;397&#46;9&#41; and ultrafiltration &#40;B&#61;0&#46;41mg&#47;mL&#59; 0&#46;02&#47;0&#46;80&#41; as independent predictors of 24-hour PPE&#46; The model also revealed a minor trend for a lower 24-hour PPE as time on PD increases&#46; <span class="elsevierStyleBold">Conclusions&#58;</span> The individual characteristics of peritoneal protein transport are the major determinants of 24-hour PPE&#46; The use of CAPD as the dialysis modality is associated with higher PPE rates than the APD technique&#44; although this difference is counterbalanced by a direct correlation between PPE and the volume of dialysate infused per day&#46; Ultrafiltration and time on dialysis also act as minor independent predictors of PPE during PD therapy&#46;</p>"
      ]
    ]
    "multimedia" => array:5 [
      0 => array:8 [
        "identificador" => "fig1"
        "etiqueta" => "Tab.  3"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "copyright" => "Elsevier Espa&#241;a"
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "11465_16025_29133_en_t311465.jpg"
            "Alto" => 937
            "Ancho" => 2183
            "Tamanyo" => 872635
          ]
        ]
        "descripcion" => array:1 [
          "en" => "Univariate correlations between treatment prescription and optimisation and 24-hour peritoneal equilibrium test"
        ]
      ]
      1 => array:8 [
        "identificador" => "fig2"
        "etiqueta" => "Tab.  1"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "copyright" => "Elsevier Espa&#241;a"
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "11465_16025_38388_en_t111465.jpg"
            "Alto" => 1249
            "Ancho" => 2168
            "Tamanyo" => 741296
          ]
        ]
        "descripcion" => array:1 [
          "en" => "General characteristics of the study groups at the start of peritoneal dialysis"
        ]
      ]
      2 => array:8 [
        "identificador" => "fig3"
        "etiqueta" => "Tab.  2"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "copyright" => "Elsevier Espa&#241;a"
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "11465_16025_38389_en_t211465.jpg"
            "Alto" => 1564
            "Ancho" => 2155
            "Tamanyo" => 1196441
          ]
        ]
        "descripcion" => array:1 [
          "en" => "Variables for treatment prescription and optimisation"
        ]
      ]
      3 => array:8 [
        "identificador" => "fig4"
        "etiqueta" => "Tab.  4"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "copyright" => "Elsevier Espa&#241;a"
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "11465_16025_38391_en_t411465.jpg"
            "Alto" => 837
            "Ancho" => 2181
            "Tamanyo" => 611303
          ]
        ]
        "descripcion" => array:1 [
          "en" => "Predictors for 24-hour peritoneal protein excretion&#46; Multi-level mixed model&#46; Best model"
        ]
      ]
      4 => array:8 [
        "identificador" => "fig5"
        "etiqueta" => "Fig. 1"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "copyright" => "Elsevier Espa&#241;a"
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "11465_16025_38392_en_f111465.jpg"
            "Alto" => 1003
            "Ancho" => 1016
            "Tamanyo" => 156353
          ]
        ]
        "descripcion" => array:1 [
          "en" => "Peritoneal protein excretion in 24 hours in patients treated with continuous ambulatory peritoneal dialysis or automated peritoneal dialysis during the follow-up period &#40;according to treatment type&#41;"
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/20132514/0000003200000006/v0_201502091602/X2013251412002272/v0_201502091603/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "35441"
    "tipo" => "SECCION"
    "en" => array:2 [
      "titulo" => "Originals"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "en"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/20132514/0000003200000006/v0_201502091602/X2013251412002272/v0_201502091603/en/P1-E544-S3760-A11465-EN.pdf?idApp=UINPBA000064&text.app=https://revistanefrologia.com/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251412002272?idApp=UINPBA000064"
]
Share
Journal Information

Statistics

Follow this link to access the full text of the article

Effect of dialysis modality and other prescription factors on peritoneal protein excretion in peritoneal dialysis
Efecto de la modalidad de diálisis y otros factores de prescripción sobre las pérdidas proteicas peritoneales en diálisis peritoneal
Ana Rodríguez-Carmonaa, Miguel Pérez Fontánb, Miguel Pérez-Fontána, Sonia Pértega Díazc, Sonia Pértega-Díazd, Beatriz López Calviñoc, Beatriz López-Calviñod, Andrés López Muñizb, Andrés López-Muñiza, Teresa García Falcónb, Teresa García-Falcóna
a Servicio de Nefrología, Complejo Hospitalario Universitario A Coruña,
b Nefrología, Complejo Hospitalario Universitario A Coruña, A Coruña, A Coruña, Spain,
c Epidemiología, Complejo Hospitalario Universitario A Coruña, A Coruña, A Coruña, Spain,
d Servicio de Epidemiología, Complejo Hospitalario Universitario A Coruña,
Read
9659
Times
was read the article
2485
Total PDF
7174
Total HTML
Share statistics
 array:21 [
  "pii" => "X2013251412002272"
  "issn" => "20132514"
  "doi" => "10.3265/Nefrologia.pre2012.Jul.11465"
  "estado" => "S300"
  "fechaPublicacion" => "2012-11-01"
  "documento" => "article"
  "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
  "subdocumento" => "fla"
  "cita" => "Nefrologia &#40;English Version&#41;. 2012;32:782-9"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 5667
    "formatos" => array:3 [
      "EPUB" => 282
      "HTML" => 4696
      "PDF" => 689
    ]
  ]
  "Traduccion" => array:1 [
    "es" => array:17 [
      "pii" => "X0211699512002275"
      "issn" => "02116995"
      "doi" => "10.3265/Nefrologia.pre2012.Jul.11465"
      "estado" => "S300"
      "fechaPublicacion" => "2012-11-01"
      "documento" => "article"
      "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
      "subdocumento" => "fla"
      "cita" => "Nefrologia. 2012;32:782-9"
      "abierto" => array:3 [
        "ES" => true
        "ES2" => true
        "LATM" => true
      ]
      "gratuito" => true
      "lecturas" => array:2 [
        "total" => 7718
        "formatos" => array:3 [
          "EPUB" => 318
          "HTML" => 6769
          "PDF" => 631
        ]
      ]
      "es" => array:12 [
        "idiomaDefecto" => true
        "titulo" => "Efecto de la modalidad de di&#225;lisis y otros factores de prescripci&#243;n sobre las p&#233;rdidas proteicas peritoneales en di&#225;lisis peritoneal"
        "tienePdf" => "es"
        "tieneTextoCompleto" => "es"
        "tieneResumen" => array:2 [
          0 => "es"
          1 => "en"
        ]
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "782"
            "paginaFinal" => "789"
          ]
        ]
        "titulosAlternativos" => array:1 [
          "en" => array:1 [
            "titulo" => "Effect of dialysis modality and other prescription factors on peritoneal protein excretion in peritoneal dialysis"
          ]
        ]
        "contieneResumen" => array:2 [
          "es" => true
          "en" => true
        ]
        "contieneTextoCompleto" => array:1 [
          "es" => true
        ]
        "contienePdf" => array:1 [
          "es" => true
        ]
        "resumenGrafico" => array:2 [
          "original" => 0
          "multimedia" => array:8 [
            "identificador" => "fig1"
            "etiqueta" => "Tab.  1"
            "tipo" => "MULTIMEDIAFIGURA"
            "mostrarFloat" => true
            "mostrarDisplay" => false
            "copyright" => "Elsevier Espa&#241;a"
            "figura" => array:1 [
              0 => array:4 [
                "imagen" => "11465_19759_29134_es_11465_t1.jpg"
                "Alto" => 350
                "Ancho" => 600
                "Tamanyo" => 188045
              ]
            ]
            "descripcion" => array:1 [
              "es" => "Caracter&#237;sticas generales de los grupos de estudio al inicio de di&#225;lisis peritoneal"
            ]
          ]
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "Ana Rodr&#237;guez-Carmona, Miguel P&#233;rez Font&#225;n, Miguel P&#233;rez-Font&#225;n, Sonia P&#233;rtega D&#237;az, Sonia P&#233;rtega-D&#237;az, Beatriz L&#243;pez Calvi&#241;o, Beatriz L&#243;pez-Calvi&#241;o, Andr&#233;s L&#243;pez Mu&#241;iz, Andr&#233;s L&#243;pez-Mu&#241;iz, Teresa Garc&#237;a Falc&#243;n, Teresa Garc&#237;a-Falc&#243;n"
            "autores" => array:11 [
              0 => array:2 [
                "nombre" => "Ana"
                "apellidos" => "Rodr&#237;guez-Carmona"
              ]
              1 => array:2 [
                "nombre" => "Miguel"
                "apellidos" => "P&#233;rez Font&#225;n"
              ]
              2 => array:2 [
                "nombre" => "Miguel"
                "apellidos" => "P&#233;rez-Font&#225;n"
              ]
              3 => array:2 [
                "nombre" => "Sonia"
                "apellidos" => "P&#233;rtega D&#237;az"
              ]
              4 => array:2 [
                "nombre" => "Sonia"
                "apellidos" => "P&#233;rtega-D&#237;az"
              ]
              5 => array:2 [
                "nombre" => "Beatriz"
                "apellidos" => "L&#243;pez Calvi&#241;o"
              ]
              6 => array:2 [
                "nombre" => "Beatriz"
                "apellidos" => "L&#243;pez-Calvi&#241;o"
              ]
              7 => array:2 [
                "nombre" => "Andr&#233;s"
                "apellidos" => "L&#243;pez Mu&#241;iz"
              ]
              8 => array:2 [
                "nombre" => "Andr&#233;s"
                "apellidos" => "L&#243;pez-Mu&#241;iz"
              ]
              9 => array:2 [
                "nombre" => "Teresa"
                "apellidos" => "Garc&#237;a Falc&#243;n"
              ]
              10 => array:2 [
                "nombre" => "Teresa"
                "apellidos" => "Garc&#237;a-Falc&#243;n"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "es"
      "Traduccion" => array:1 [
        "en" => array:9 [
          "pii" => "X2013251412002272"
          "doi" => "10.3265/Nefrologia.pre2012.Jul.11465"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => true
            "ES2" => true
            "LATM" => true
          ]
          "gratuito" => true
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "en"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251412002272?idApp=UINPBA000064"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699512002275?idApp=UINPBA000064"
      "url" => "/02116995/0000003200000006/v0_201502091338/X0211699512002275/v0_201502091339/es/main.assets"
    ]
  ]
  "itemSiguiente" => array:17 [
    "pii" => "X2013251412002264"
    "issn" => "20132514"
    "doi" => "10.3265/Nefrologia.pre2012.Jun.11242"
    "estado" => "S300"
    "fechaPublicacion" => "2012-11-01"
    "documento" => "article"
    "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
    "subdocumento" => "fla"
    "cita" => "Nefrologia &#40;English Version&#41;. 2012;32:790-6"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 6654
      "formatos" => array:3 [
        "EPUB" => 295
        "HTML" => 5475
        "PDF" => 884
      ]
    ]
    "en" => array:12 [
      "idiomaDefecto" => true
      "titulo" => "The effect of pentoxifylline on reduction of proteinuria among patients with type 2 diabetes under blockade of angiotensin system&#58; a double blind and randomized clinical trial"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "tieneResumen" => array:2 [
        0 => "es"
        1 => "en"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "790"
          "paginaFinal" => "796"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "El efecto de la pentoxifilina en la reducci&#243;n de proteinuria en pacientes con diabetes tipo 2 con bloqueo del sistema de angiotensina&#58; ensayo cl&#237;nico doble ciego y aleatorizado"
        ]
      ]
      "contieneResumen" => array:2 [
        "es" => true
        "en" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:8 [
          "identificador" => "fig1"
          "etiqueta" => "Tab.  1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "copyright" => "Elsevier Espa&#241;a"
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "11242_16025_23451_en_t111242.jpg"
              "Alto" => 639
              "Ancho" => 2180
              "Tamanyo" => 413272
            ]
          ]
          "descripcion" => array:1 [
            "en" => "Baseline demographic and clinical characteristics of patients"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Ali Ghorbani, Bita Omidvar, Seyed S&#46; Beladi-Mousavi, Seyed Seifollah Beladi Mousavi, Elena Lak, Sima Vaziri"
          "autores" => array:10 [
            0 => array:2 [
              "nombre" => "Ali"
              "apellidos" => "Ghorbani"
            ]
            1 => array:2 [
              "nombre" => "Ali"
              "apellidos" => "Ghorbani"
            ]
            2 => array:2 [
              "nombre" => "Bita"
              "apellidos" => "Omidvar"
            ]
            3 => array:2 [
              "nombre" => "Bita"
              "apellidos" => "Omidvar"
            ]
            4 => array:2 [
              "nombre" => "Seyed S&#46;"
              "apellidos" => "Beladi-Mousavi"
            ]
            5 => array:2 [
              "nombre" => "Seyed Seifollah"
              "apellidos" => "Beladi Mousavi"
            ]
            6 => array:2 [
              "nombre" => "Elena"
              "apellidos" => "Lak"
            ]
            7 => array:2 [
              "nombre" => "Elena"
              "apellidos" => "Lak"
            ]
            8 => array:2 [
              "nombre" => "Sima"
              "apellidos" => "Vaziri"
            ]
            9 => array:2 [
              "nombre" => "Sima"
              "apellidos" => "Vaziri"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "X0211699512002267"
        "doi" => "10.3265/Nefrologia.pre2012.Jun.11242"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699512002267?idApp=UINPBA000064"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251412002264?idApp=UINPBA000064"
    "url" => "/20132514/0000003200000006/v0_201502091602/X2013251412002264/v0_201502091603/en/main.assets"
  ]
  "itemAnterior" => array:17 [
    "pii" => "X2013251412002280"
    "issn" => "20132514"
    "doi" => "10.3265/Nefrologia.pre2012.Jul.11483"
    "estado" => "S300"
    "fechaPublicacion" => "2012-11-01"
    "documento" => "article"
    "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
    "subdocumento" => "fla"
    "cita" => "Nefrologia &#40;English Version&#41;. 2012;32:777-81"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 5838
      "formatos" => array:3 [
        "EPUB" => 290
        "HTML" => 4849
        "PDF" => 699
      ]
    ]
    "en" => array:12 [
      "idiomaDefecto" => true
      "titulo" => "Renal function assessment in non-steroidal anti-inflammatory drug prescriptions&#46; A pilot study in a primary care centre"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "tieneResumen" => array:2 [
        0 => "es"
        1 => "en"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "777"
          "paginaFinal" => "781"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Uso de antiinflamatorios no esteroideos y monitorizaci&#243;n de la funci&#243;n renal&#46; Estudio piloto en un centro de salud de Atenci&#243;n Primaria"
        ]
      ]
      "contieneResumen" => array:2 [
        "es" => true
        "en" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:8 [
          "identificador" => "fig1"
          "etiqueta" => "Fig. 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "copyright" => "Elsevier Espa&#241;a"
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "11483_16025_38431_en_f111483.jpg"
              "Alto" => 903
              "Ancho" => 2072
              "Tamanyo" => 313530
            ]
          ]
          "descripcion" => array:1 [
            "en" => "Relationship between new prescriptions and all prescriptions&#46; Percentage of non-steroidal anti-inflammatory drug &#40;NSAID&#41; prescriptions out of the total of all prescriptions"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "ITZIAR DE PABLO LOPEZ DE ABECHUCO, Itziar De Pablo-L&#243;pez de Abechuco, M ANGELES G&#193;LVEZ M&#218;GICA, M&#46; &#193;ngeles G&#225;lvez-M&#250;gica, DANIEL RODRIGUEZ, Daniel Rodr&#237;guez, JOSE MANUEL DEL REY, J&#46; Manuel Del Rey, ESTHER PRIETO, Esther Prieto, MIGUEL CUCHI, Miguel Cuchi, LUIS SANCHEZ PERUCA, Luis S&#225;nchez-Peruca, FERNANDO Lia&#241;o Garc&#237;a, Fernando Lia&#241;o-Garc&#237;a"
          "autores" => array:16 [
            0 => array:2 [
              "nombre" => "ITZIAR"
              "apellidos" => "DE PABLO LOPEZ DE ABECHUCO"
            ]
            1 => array:2 [
              "nombre" => "Itziar"
              "apellidos" => "De Pablo-L&#243;pez de Abechuco"
            ]
            2 => array:2 [
              "nombre" => "M ANGELES"
              "apellidos" => "G&#193;LVEZ M&#218;GICA"
            ]
            3 => array:2 [
              "nombre" => "M&#46; &#193;ngeles"
              "apellidos" => "G&#225;lvez-M&#250;gica"
            ]
            4 => array:2 [
              "nombre" => "DANIEL"
              "apellidos" => "RODRIGUEZ"
            ]
            5 => array:2 [
              "nombre" => "Daniel"
              "apellidos" => "Rodr&#237;guez"
            ]
            6 => array:2 [
              "nombre" => "JOSE MANUEL"
              "apellidos" => "DEL REY"
            ]
            7 => array:2 [
              "nombre" => "J&#46; Manuel"
              "apellidos" => "Del Rey"
            ]
            8 => array:2 [
              "nombre" => "ESTHER"
              "apellidos" => "PRIETO"
            ]
            9 => array:2 [
              "nombre" => "Esther"
              "apellidos" => "Prieto"
            ]
            10 => array:2 [
              "nombre" => "MIGUEL"
              "apellidos" => "CUCHI"
            ]
            11 => array:2 [
              "nombre" => "Miguel"
              "apellidos" => "Cuchi"
            ]
            12 => array:2 [
              "nombre" => "LUIS"
              "apellidos" => "SANCHEZ PERUCA"
            ]
            13 => array:2 [
              "nombre" => "Luis"
              "apellidos" => "S&#225;nchez-Peruca"
            ]
            14 => array:2 [
              "nombre" => "FERNANDO"
              "apellidos" => "Lia&#241;o Garc&#237;a"
            ]
            15 => array:2 [
              "nombre" => "Fernando"
              "apellidos" => "Lia&#241;o-Garc&#237;a"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "X0211699512002283"
        "doi" => "10.3265/Nefrologia.pre2012.Jul.11483"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699512002283?idApp=UINPBA000064"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251412002280?idApp=UINPBA000064"
    "url" => "/20132514/0000003200000006/v0_201502091602/X2013251412002280/v0_201502091603/en/main.assets"
  ]
  "en" => array:14 [
    "idiomaDefecto" => true
    "titulo" => "Effect of dialysis modality and other prescription factors on peritoneal protein excretion in peritoneal dialysis"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "782"
        "paginaFinal" => "789"
      ]
    ]
    "autores" => array:1 [
      0 => array:3 [
        "autoresLista" => "Ana Rodr&#237;guez-Carmona, Miguel P&#233;rez Font&#225;n, Miguel P&#233;rez-Font&#225;n, Sonia P&#233;rtega D&#237;az, Sonia P&#233;rtega-D&#237;az, Beatriz L&#243;pez Calvi&#241;o, Beatriz L&#243;pez-Calvi&#241;o, Andr&#233;s L&#243;pez Mu&#241;iz, Andr&#233;s L&#243;pez-Mu&#241;iz, Teresa Garc&#237;a Falc&#243;n, Teresa Garc&#237;a-Falc&#243;n"
        "autores" => array:11 [
          0 => array:3 [
            "nombre" => "Ana"
            "apellidos" => "Rodr&#237;guez-Carmona"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "affa"
              ]
            ]
          ]
          1 => array:4 [
            "nombre" => "Miguel"
            "apellidos" => "P&#233;rez Font&#225;n"
            "email" => array:1 [
              0 => "miguel&#46;perez&#46;fontan&#64;sergas&#46;es"
            ]
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "affb"
              ]
            ]
          ]
          2 => array:4 [
            "nombre" => "Miguel"
            "apellidos" => "P&#233;rez-Font&#225;n"
            "email" => array:1 [
              0 => "miguel&#46;perez&#46;fontan&#64;sergas&#46;es"
            ]
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "affa"
              ]
            ]
          ]
          3 => array:3 [
            "nombre" => "Sonia"
            "apellidos" => "P&#233;rtega D&#237;az"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">c</span>"
                "identificador" => "affc"
              ]
            ]
          ]
          4 => array:3 [
            "nombre" => "Sonia"
            "apellidos" => "P&#233;rtega-D&#237;az"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">d</span>"
                "identificador" => "affd"
              ]
            ]
          ]
          5 => array:3 [
            "nombre" => "Beatriz"
            "apellidos" => "L&#243;pez Calvi&#241;o"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">c</span>"
                "identificador" => "affc"
              ]
            ]
          ]
          6 => array:3 [
            "nombre" => "Beatriz"
            "apellidos" => "L&#243;pez-Calvi&#241;o"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">d</span>"
                "identificador" => "affd"
              ]
            ]
          ]
          7 => array:3 [
            "nombre" => "Andr&#233;s"
            "apellidos" => "L&#243;pez Mu&#241;iz"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "affb"
              ]
            ]
          ]
          8 => array:3 [
            "nombre" => "Andr&#233;s"
            "apellidos" => "L&#243;pez-Mu&#241;iz"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "affa"
              ]
            ]
          ]
          9 => array:3 [
            "nombre" => "Teresa"
            "apellidos" => "Garc&#237;a Falc&#243;n"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "affb"
              ]
            ]
          ]
          10 => array:3 [
            "nombre" => "Teresa"
            "apellidos" => "Garc&#237;a-Falc&#243;n"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "affa"
              ]
            ]
          ]
        ]
        "afiliaciones" => array:4 [
          0 => array:3 [
            "entidad" => "Servicio de Nefrología, Complejo Hospitalario Universitario A Coruña,    "
            "etiqueta" => "<span class="elsevierStyleSup">a</span>"
            "identificador" => "affa"
          ]
          1 => array:3 [
            "entidad" => "Nefrología, Complejo Hospitalario Universitario A Coruña, A Coruña, A Coruña, Spain, "
            "etiqueta" => "<span class="elsevierStyleSup">b</span>"
            "identificador" => "affb"
          ]
          2 => array:3 [
            "entidad" => "Epidemiología, Complejo Hospitalario Universitario A Coruña, A Coruña, A Coruña, Spain, "
            "etiqueta" => "<span class="elsevierStyleSup">c</span>"
            "identificador" => "affc"
          ]
          3 => array:3 [
            "entidad" => "Servicio de Epidemiología, Complejo Hospitalario Universitario A Coruña,    "
            "etiqueta" => "<span class="elsevierStyleSup">d</span>"
            "identificador" => "affd"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "es" => array:1 [
        "titulo" => "Efecto de la modalidad de di&#225;lisis y otros factores de prescripci&#243;n sobre las p&#233;rdidas proteicas peritoneales en di&#225;lisis peritoneal"
      ]
    ]
    "resumenGrafico" => array:2 [
      "original" => 0
      "multimedia" => array:8 [
        "identificador" => "fig1"
        "etiqueta" => "Tab.  3"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "copyright" => "Elsevier Espa&#241;a"
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "11465_16025_29133_en_t311465.jpg"
            "Alto" => 937
            "Ancho" => 2183
            "Tamanyo" => 872635
          ]
        ]
        "descripcion" => array:1 [
          "en" => "Univariate correlations between treatment prescription and optimisation and 24-hour peritoneal equilibrium test"
        ]
      ]
    ]
    "textoCompleto" => "<p class="elsevierStylePara"><span class="elsevierStyleBold">INTRODUCTION</span></p><p class="elsevierStylePara">&#160;</p><p class="elsevierStylePara">Peritoneal protein excretion &#40;PPE&#41; is an undesired consequence of peritoneal dialysis &#40;PD&#41; that contributes to a varying degree to malnutrition<span class="elsevierStyleSup">1</span> and other complications inherent to this technique&#46;<span class="elsevierStyleSup">2-4</span> Scarce information is available regarding the factors that affect the magnitude of PPE in daily clinical practice&#44; apart from the expected correlation with general peritoneal transport characteristics&#46;<span class="elsevierStyleSup">5-8</span> It is unclear what sort of effect the conditions of the dialysis prescription&#44; and the modality of PD in particular&#44; have on this parameter&#46; Previous attempts to clarify this issue have been limited by the notable disparities between the populations compared&#46; The type of peritoneal transport will also influence the prescription provided&#44; including the decision between continuous ambulatory peritoneal dialysis &#40;CAPD&#41; or automated peritoneal dialysis &#40;APD&#41;&#46; Stratified multivariate analysis techniques aid in adjusting for these variables&#44; but the use of peritoneal creatinine transport for this purpose is inadequate&#44; since this variable provides little predictive value for peritoneal protein transport&#46;<span class="elsevierStyleSup">9&#44;10</span></p><p class="elsevierStylePara">We present the results of an observational study involving a large cohort of incident patients on PD&#44; with the primary objective of establishing the influence of prescription characteristics &#40;including modality of PD&#41; on PPE during a 24-hour period&#44; taking advantage of the standardised measurements of peritoneal protein transport taken during serial peritoneal equilibrium tests &#40;PET&#41;&#46;</p><p class="elsevierStylePara">&#160;</p><p class="elsevierStylePara"><span class="elsevierStyleBold">POPULATION AND METHOD</span></p><p class="elsevierStylePara">&#160;</p><p class="elsevierStylePara"><span class="elsevierStyleBold">Study design</span></p><p class="elsevierStylePara">&#160;</p><p class="elsevierStylePara">Ours was a prospective and observational study examining a cohort of incident patients on PD treated at our hospital between January 2000 and June 2010&#46; The inclusion criteria used were&#58; minimum of two months on dialysis treatment with no registered cases of peritonitis and availability of initial 24-hour PPE measurements and during the first PET&#46; The primary study variable was the magnitude of PPE in PD effluent during a 24-hour period&#46; The primary adjustment variable was an estimate of peritoneal protein transport during a standard PET using a 2&#46;27&#37; glucose solution&#46; We also examined standard demographic&#44; clinical&#44; and laboratory parameters in order to obtain adjusted estimates&#46;</p><p class="elsevierStylePara">At our hospital&#44; traditional PD solutions were used until May 2008&#46; After this point&#44; all patients were treated using solutions with low concentrations of glucose degradation products&#46;</p><p class="elsevierStylePara">The study protocol was in accordance with the ethical criteria required for observational studies at our hospital as well as the Helsinki Declaration&#46;</p><p class="elsevierStylePara">&#160;</p><p class="elsevierStylePara"><span class="elsevierStyleBold">Laboratory methods and secondary calculations</span></p><p class="elsevierStylePara">&#160;</p><p class="elsevierStylePara">Blood levels of haemoglobin&#44; glucose&#44; urea&#44; creatinine&#44; albumin&#44; and cholesterol were estimated using a standard auto-analyser&#46; Glucose and creatinine levels in the dialysate fluid and urea and creatinine levels in urine samples were measured using procedures specifically designed for the same auto-analyser&#46; Plasma C-reactive protein &#40;CRP&#41; was measured using an immunoturbidimetric test &#40;Roche Diag&#46;&#44; Mannheim&#44; Germany&#41;&#46; We also used a modified colorimetric test &#40;pirogalol red&#41; to measure total protein content of urine samples and peritoneal effluent&#46; In a previous study&#44;<span class="elsevierStyleSup">10</span> we showed this to be an appropriate technique that is not affected by sample storage or by high concentrations of glucose present in the dialysate&#46;</p><p class="elsevierStylePara">We used universally accepted procedures for performing PET&#46; Glomerular filtration rate was estimated as the mean 24-hour clearance rates of urea and creatinine&#46; Mean daily ultrafiltration rate &#40;UF&#41; and blood pressure were compiled from the registries of daily values recorded by the patients themselves&#46;</p><p class="elsevierStylePara">&#160;</p><p class="elsevierStylePara"><span class="elsevierStyleBold">Strategy of analysis </span></p><p class="elsevierStylePara">&#160;</p><p class="elsevierStylePara">We compared the temporal progression of 24-hour PPE between patients treated with CAPD and those treated with APD until the end of the second year of follow-up&#44; using both strategies of intention to treat and final treatment&#46; Results were similar under both approaches&#44; and the results presented in this article are derived from final treatment strategies&#46; We also monitored longitudinal differences in demographic and clinical parameters&#44; peritoneal function&#44; prescription&#44; and optimisation of treatment&#44; searching for univariate correlations with 24-hour PPE&#46; However&#44; our primary objective was to analyse how the conditions of peritoneal dialysis prescriptions affected the primary study variable&#44; taking into account possible temporal variation in PPE and the change produced to the PD prescription &#40;including the modality of dialysis&#41; during the follow-up period&#46;</p><p class="elsevierStylePara">&#160;</p><p class="elsevierStylePara"><span class="elsevierStyleBold">Statistical analysis</span></p><p class="elsevierStylePara">&#160;</p><p class="elsevierStylePara">Numerical variables are presented as mean &#177; standard deviation or median and range&#44; as appropriate&#46; Univariate comparisons were performed using Student&#8217;s t-test&#44; ANOVA&#44; and Mann-Whitney and Wilcoxon tests &#40;numerical variables&#41; and chi-square distribution &#40;categorical variables&#41;&#46; We also calculated correlations between numerical variables using Spearman&#8217;s test&#46; We used a generalised linear model with repeated measures to analyse univariate tendencies over time&#44; both for 24-hour PPE and for PPE during serial PETs&#46;</p><p class="elsevierStylePara">We also performed a multivariate analysis using multi-level mixed linear models&#44; selecting variables using forwards stepwise selection&#46; The effect of patient heterogeneity was adjusted for as a random effect&#44; while the covariates analysed were adjusted for as fixed effects&#46; Serial measurements of PPE during PET&#44; which represented the individual characteristics of peritoneal protein transport over time&#44; were included systematically in all models tested&#46; We also analysed the potential effects of cardiovascular events &#40;only those that required hospitalisation&#41; and peritonitis during the follow-up period&#44; as well as for the potential effects of treatment with angiotensin-converting enzyme &#40;ACE&#41; inhibitors and angiotensin receptor blockers &#40;ARB&#41; on the progression of PPE over time&#46; Associations between the study variables and PPE were estimated using beta coefficients &#40;with 95&#37; confidence intervals &#91;CI&#93;&#41; in the fixed effects section of the statistical models&#46; We also analysed interaction terms&#46; Finally&#44; we used Bayesian &#40;BIC&#41; and Akaike&#8217;s information criteria &#40;AIC&#41; to compare maximum likelihood models&#46;</p><p class="elsevierStylePara">We used SPSS &#40;v&#46;18&#46;0&#41; and Stat &#40;v&#46;11&#41; statistical software for all statistical analyses&#46;</p><p class="elsevierStylePara">&#160;</p><p class="elsevierStylePara"><span class="elsevierStyleBold">RESULTS</span></p><p class="elsevierStylePara">&#160;</p><p class="elsevierStylePara">Of the 313 patients evaluated&#44; 284 complied with the study inclusion criteria&#46; Table 1 summarises the general characteristics of the study population at the start of PD&#46; Fifteen patients &#40;5&#46;3&#37;&#41; suffered at least one cardiovascular event during the first 6 months&#44; 24 &#40;8&#46;5&#37;&#41; between months 6 and 12&#44; and 49 &#40;17&#46;3&#37;&#41; during the second year of the follow-up regimen&#46; The cumulative incidences of peritonitis were 59 &#40;20&#46;8&#37;&#41;&#44; 45 &#40;15&#46;8&#37;&#41;&#44; and 26 &#40;9&#46;2&#37;&#41;&#44; respectively&#46; Table 2 demonstrates the parameters for prescription and treatment optimisation compiled during the follow-up period&#46; Only two patients had dry-day regimens at the start of PD&#44; and four others were prescribed dry days at some other point during follow-up&#46; The majority of the differences observed were expected&#44; but surprisingly&#44; PPE during serial PETs was consistently higher in patients on CAPD&#44; while small solute transport &#40;P&#47;D creatinine at 4 hours &#91;P&#47;D<span class="elsevierStyleInf">crea</span>&#93;&#41; was higher in patients treated with APD&#44; although this difference was only significant in baseline measurements &#40;Table 2&#41;&#46;</p><p class="elsevierStylePara">Changes in the type of PD administered were relatively common&#44; and involved switching from CAPD to APD in 43 cases and switching from APD to CAPD in 4&#46; Table 3 shows the primary univariate correlations between 24-hour PPE and variables of treatment optimisation and prescription&#46; The primary study variable was also significantly correlated with baseline Charlson comorbidity index &#40;r&#61;0&#46;16&#59; <span class="elsevierStyleItalic">P</span>&#61;&#46;006&#41; and CRP &#40;r&#61;0&#46;15&#59; <span class="elsevierStyleItalic">P</span>&#61;&#46;014&#41;&#46; Univariate analyses based on intention to treat and based on final treatment &#40;Table 2&#44; Figure 1&#41; tended towards higher 24-hour PPE in patients on CAPD&#44; although the difference only reached statistical significance after 24 months&#46; On the other hand&#44; univariate analyses with repeated measures showed no significant long-term changes for PPE during PET or in a 24-hour period&#44; neither in the overall group nor based on modality of PD or the presence&#47;absence of peritonitis during the first year of follow-up&#46;</p><p class="elsevierStylePara">The multi-level mixed models &#40;Table 4&#41; identified CAPD &#40;vs&#46; APD&#41;&#44; total volume infused in 24 hours&#44; and daily UF as independent predictors of 24-hour PPE&#44; after adjusting for standardised peritoneal protein transport &#40;PPT&#41;&#46; Total volume drained acted in the models as a surrogate for infused volume and UF &#40;B&#61;297&#46;9&#59; 95&#37; CI&#58; 203&#46;6&#47;292&#46;3&#59; <span class="elsevierStyleItalic">P</span>&#60;&#46;0005&#41;&#46; All variables included in the final model had a significant impact on both AIC and BIC with the exception of daily UF&#44; suggesting that this variable has little practical influence on 24-hour PPE&#46; We detected no significant interaction terms between the variables in the final model except for a minor interaction between PPE during PET and total volume infused &#40;B&#61;-0&#46;18&#59; 95&#37; CI&#58; -0&#46;6&#47;-0&#46;01&#59; <span class="elsevierStyleItalic">P</span>&#61;&#46;039&#41;&#44; which we ignored in order to give greater clarity to the presentation of our results&#46; No other variables related to clinical results&#44; optimisation of treatment&#44; or prescription &#40;Table 3&#41; were independently correlated with 24-hour PPE&#46; In particular&#44; cardiovascular events &#40;B&#61;-149&#46;9&#59; 95&#37; CI&#58; -969&#46;5&#47;669&#46;7&#59; <span class="elsevierStyleItalic">P</span>&#61;&#46;72&#41;&#44; peritonitis &#40;B&#61;389&#46;0&#59; 95&#37; CI&#58; -117&#46;6&#47;895&#46;7&#59; <span class="elsevierStyleItalic">P</span>&#61;&#46;13&#41;&#44; and treatment with ACE&#47;ARB &#40;B&#61;-17&#46;6&#59; 95&#37; CI&#58; 443&#46;2&#47;407&#46;9&#59; <span class="elsevierStyleItalic">P</span>&#61;&#46;94&#41; all failed to show a time-dependent correlation with 24-hour PPE&#46;</p><p class="elsevierStylePara">The multivariate analysis showed tendencies towards decreased PPE during follow-up&#44; although this effect only reached statistical significance after 12 months &#40;Table 4&#41;&#46; We performed a stratified statistical analysis in order to rule out the possibility that this effect might be the consequence of an earlier exit from PD in patients with a greater rate of 24-hour PPE&#46; The analysis showed slight and non-significant tendencies towards increased rates of late exit from PD &#40;24 months&#41; in patients in the first and fourth quartile of PPE results taken during PET&#46;</p><p class="elsevierStylePara">&#160;</p><p class="elsevierStylePara"><span class="elsevierStyleBold">DISCUSSION</span></p><p class="elsevierStylePara">&#160;</p><p class="elsevierStylePara">PPE is correlated with general characteristics of peritoneal transport in each individual&#46; However&#44; the use of estimators of small solute transport as a marker for proteins is quite unreliable&#44; since despite the fact that the correlation between PPE and P&#47;D<span class="elsevierStyleInf">crea</span> is statistically significant&#44; it is far from being unequivocal&#46;<span class="elsevierStyleSup">9&#44;10</span> This limitation is logical&#44; given the fact that different pathways are used for peritoneal transport of proteins and of small solutes&#46;<span class="elsevierStyleSup">11</span> If we wish to perform an adjusted evaluation of the effect of other factors on 24-hour PPE&#44; there is no specific marker available for the characteristics of peritoneal protein transport&#46; In previous studies&#44; we showed that a standardised estimate of protein transport during PET is useful for this objective&#46;<span class="elsevierStyleSup">10&#44;12</span></p><p class="elsevierStylePara">Several studies have explored the possibility of using common demographic and clinical markers of peritoneal protein transport in patients on PD&#46; Advanced age&#44; diabetes&#44; cardiovascular comorbidity factors&#44; obesity&#47;overweight&#44; residual renal function&#44; proteinuria&#44; and plasma CRP are some of the most frequently cited factors&#46;<span class="elsevierStyleSup">8-14 A</span> comprehensive evaluation suggests that PPE is associated with cardiovascular disease&#44; supporting the hypothesis that this serves as a marker for large peritoneal pore disorders&#44; and indirectly&#44; for endothelial dysfunction&#46;<span class="elsevierStyleSup">15&#44;16</span> In fact&#44; some studies have demonstrated an association between PPE at the start of PD and mortality while on PD&#46;<span class="elsevierStyleSup">9&#44;12</span> In our study&#44; we observed a univariate association between PPE and Charlson comorbidity index and plasma CRP&#44; although the correlation disappears after adjusting for peritoneal protein transport during PET&#46;</p><p class="elsevierStylePara">Very few studies have examined the influence of the conditions of the PD prescription on 24-hour PPE&#46; Kathuria et al&#46;<span class="elsevierStyleSup">5</span> compared PPE in patients treated with CAPD and nocturnal intermittent PD &#40;NIPD&#41;&#44; observing no consistent differences between the two modalities&#44; even after stratifying patients based on peritoneal transport of small molecules &#40;P&#47;D<span class="elsevierStyleInf">crea</span>&#41;&#46; On the other hand&#44; Heaf et al&#46;<span class="elsevierStyleSup">15</span> observed lower PPE values during NIPD than in patients on APD with wet day&#46; In a smaller study&#44; Westra et al&#46;<span class="elsevierStyleSup">17</span> observed relatively high levels of PPE in nine patients treated with APD&#46; Both an increase in the number of cycles administered and a longer duration of treatment appear to be associated with higher PPE&#46;<span class="elsevierStyleSup">17</span> However&#44; the design of this study&#44; which lacked a control group on CAPD&#44; does not allow for drawing clear conclusions based on these results&#46;</p><p class="elsevierStylePara">In our study&#44; patients on CAPD had different peritoneal protein transport characteristics &#40;estimated during serial PETs&#41; than patients on APD &#40;Table 2&#41;&#46; This difference alone could explain why the simple analysis of 24-hour PPE showed the tendency for higher levels in patients on CAPD than in those on APD &#40;Table 2&#41;&#46; On the other hand&#44; the univariate tests for repeated measures detected a notable stability in PPE during PET and as measured over 24 hours&#44; which is in agreement with the results from previous studies&#46;<span class="elsevierStyleSup">8</span> The multi-level mixed models &#40;Table 4&#41; showed that the conditions of the prescription of PD can also influence 24-hour PPE&#46; Both total infusion volume and daily UF were directly and independently correlated with the primary study variable&#46; UF can be considered as a simple complementary metric to infused volume&#44; but the possibility of a specific effect of this variable on peritoneal protein transport is a controversial subject&#46; Recent authors have shown a direct correlation between these two variables&#44;<span class="elsevierStyleSup">8&#44;10</span> whereas a previous study by Waniewski et al&#46;<span class="elsevierStyleSup">18</span> showed that UF can be directly and inversely correlated with PPE&#44; depending on the category of peritoneal transport that the patient falls under&#44; with practically neutral effects when analysing the total population treated with PD&#46; The lack of a significant impact of UF on AIC and BIC in the multivariate analysis suggests scarce clinical relevance for this variable&#46;</p><p class="elsevierStylePara">The use of CAPD was associated with higher 24-hour PPE values than APD&#44; after adjusting for the characteristics of peritoneal protein transport &#40;PET&#41; and total volume infused&#46; The significance of this finding is unclear&#44; and we cannot rule out that it is the product of a residual bias derived from an incomplete adjustment for other factors in the analysis&#46; The use of APD&#44; based on shorter and more frequent cycles&#44; could be the cause of slightly but significantly lower PPE values&#44; given the accumulation of infusion and drainage times&#46; The impact of this factor should not be so important if we assume that peritoneal protein transport is linear during exchanges&#44; in contrast to the pattern of small solute transport&#46;<span class="elsevierStyleSup">19 </span>We should also point out that other studies have suggested that peritoneal protein excretion could be faster during the first hour of dialysis<span class="elsevierStyleSup">18</span> and then assume a linear pattern as the session progresses&#46; If this were true&#44; we might even expect greater PPE in the short exchanges typical of APD&#46; However&#44; this phenomenon is probably the result of both the mixture of residual volume&#44; which is rich in proteins&#44; with the recently infused dialysate&#44; and the phenomenon of proteins being drawn from the interstitial space into the peritoneal cavity during the early stage of each exchange&#46; Either of these effects could be relevant during long-duration dialysis sessions &#40;such as those performed in CAPD&#41;&#44; but only during the first of a series of short exchanges &#40;such as in APD&#41;&#46;</p><p class="elsevierStylePara">Our study did involve certain limitations&#44; including a non-randomised assignment of patients to the different modalities of PD&#46; In addition&#44; a portion of our study patients switched PD modalities during the follow-up period&#44; mostly from CAPD to APD&#44; and membrane dysfunction could prompt some of these changes&#46; The multivariate strategy and time-dependent statistical analysis were designed to compensate for these potential biases&#46; In addition&#44; our hospital does not routinely administer NIPD&#44; which impedes our ability to draw valid conclusions with respect to this modality of APD&#46; Finally&#44; the majority of patients were treated using traditional PD solutions&#46; However&#44; a recent short-term study at our hospital demonstrated similar PPE rates in patients treated with traditional or biocompatible solutions&#46;<span class="elsevierStyleSup">20</span> Our study also presents qualities that provide substantial robustness to our conclusions&#46; First&#44; the study population was quite large&#44; allowing for drawing conclusions based on significant results&#46; The available clinical information was also quite complete&#44; and the study design allowed for both cross-sectional and longitudinal comparisons&#46; Finally&#44; the availability of standardised estimates of peritoneal protein transport in serial PETs allowed for the use of this variable in order to adjust for the expected heterogeneity among individual characteristics of peritoneal transport&#44; particularly when comparing between patients on CAPD and those on APD&#46;</p><p class="elsevierStylePara">To conclude&#44; the individual characteristics of peritoneal protein transport represent a basic determining factor for 24-hour PPE in patients on PD&#44; but the conditions of the dialysis prescription also can influence this variable&#46; The CAPD modality is associated with greater PPE than APD&#44; although this difference is compensated by the direct association between PPE and total volume infused &#40;which tends to be greater in CAPD&#41;&#46; Daily UF and time on PD were secondary independent markers of PPE in patients on PD&#46;</p><p class="elsevierStylePara">&#160;</p><p class="elsevierStylePara"><span class="elsevierStyleBold">Conflicts of interest</span></p><p class="elsevierStylePara">&#160;</p><p class="elsevierStylePara">The authors declare that they have no potential conflicts of interest related to the contents of this article&#46;</p><p class="elsevierStylePara"><a href="grande&#47;11465&#95;16025&#95;29133&#95;en&#95;t311465&#46;jpg" class="elsevierStyleCrossRefs"><img src="11465_16025_29133_en_t311465.jpg" alt="Univariate correlations between treatment prescription and optimisation and 24-hour peritoneal equilibrium test"></img></a></p><p class="elsevierStylePara">Table 3&#46; Univariate correlations between treatment prescription and optimisation and 24-hour peritoneal equilibrium test</p><p class="elsevierStylePara"><a href="grande&#47;11465&#95;16025&#95;38388&#95;en&#95;t111465&#46;jpg" class="elsevierStyleCrossRefs"><img src="11465_16025_38388_en_t111465.jpg" alt="General characteristics of the study groups at the start of peritoneal dialysis"></img></a></p><p class="elsevierStylePara">Table 1&#46; General characteristics of the study groups at the start of peritoneal dialysis</p><p class="elsevierStylePara"><a href="grande&#47;11465&#95;16025&#95;38389&#95;en&#95;t211465&#46;jpg" class="elsevierStyleCrossRefs"><img src="11465_16025_38389_en_t211465.jpg" alt="Variables for treatment prescription and optimisation"></img></a></p><p class="elsevierStylePara">Table 2&#46; Variables for treatment prescription and optimisation</p><p class="elsevierStylePara"><a href="grande&#47;11465&#95;16025&#95;38391&#95;en&#95;t411465&#46;jpg" class="elsevierStyleCrossRefs"><img src="11465_16025_38391_en_t411465.jpg" alt="Predictors for 24-hour peritoneal protein excretion&#46; Multi-level mixed model&#46; Best model"></img></a></p><p class="elsevierStylePara">Table 4&#46; Predictors for 24-hour peritoneal protein excretion&#46; Multi-level mixed model&#46; Best model</p><p class="elsevierStylePara"><a href="grande&#47;11465&#95;16025&#95;38392&#95;en&#95;f111465&#46;jpg" class="elsevierStyleCrossRefs"><img src="11465_16025_38392_en_f111465.jpg" alt="Peritoneal protein excretion in 24 hours in patients treated with continuous ambulatory peritoneal dialysis or automated peritoneal dialysis during the follow-up period &#40;according to treatment type&#41;"></img></a></p><p class="elsevierStylePara">Figure 1&#46; Peritoneal protein excretion in 24 hours in patients treated with continuous ambulatory peritoneal dialysis or automated peritoneal dialysis during the follow-up period &#40;according to treatment type&#41;</p>"
    "pdfFichero" => "P1-E544-S3760-A11465-EN.pdf"
    "tienePdf" => true
    "PalabrasClave" => array:2 [
      "es" => array:5 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Palabras clave"
          "identificador" => "xpalclavsec437077"
          "palabras" => array:1 [
            0 => "Di&#225;lisis peritoneal autom&#225;tica"
          ]
        ]
        1 => array:4 [
          "clase" => "keyword"
          "titulo" => "Palabras clave"
          "identificador" => "xpalclavsec437079"
          "palabras" => array:1 [
            0 => "Prescripci&#243;n"
          ]
        ]
        2 => array:4 [
          "clase" => "keyword"
          "titulo" => "Palabras clave"
          "identificador" => "xpalclavsec437081"
          "palabras" => array:1 [
            0 => "Prueba de equilibrio peritoneal"
          ]
        ]
        3 => array:4 [
          "clase" => "keyword"
          "titulo" => "Palabras clave"
          "identificador" => "xpalclavsec437083"
          "palabras" => array:1 [
            0 => "Prote&#237;na"
          ]
        ]
        4 => array:4 [
          "clase" => "keyword"
          "titulo" => "Palabras clave"
          "identificador" => "xpalclavsec437085"
          "palabras" => array:1 [
            0 => "DPCA"
          ]
        ]
      ]
      "en" => array:5 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Keywords"
          "identificador" => "xpalclavsec437078"
          "palabras" => array:1 [
            0 => "Automated PD"
          ]
        ]
        1 => array:4 [
          "clase" => "keyword"
          "titulo" => "Keywords"
          "identificador" => "xpalclavsec437080"
          "palabras" => array:1 [
            0 => "Prescription"
          ]
        ]
        2 => array:4 [
          "clase" => "keyword"
          "titulo" => "Keywords"
          "identificador" => "xpalclavsec437082"
          "palabras" => array:1 [
            0 => "Peritoneal equilibration test"
          ]
        ]
        3 => array:4 [
          "clase" => "keyword"
          "titulo" => "Keywords"
          "identificador" => "xpalclavsec437084"
          "palabras" => array:1 [
            0 => "Protein"
          ]
        ]
        4 => array:4 [
          "clase" => "keyword"
          "titulo" => "Keywords"
          "identificador" => "xpalclavsec437086"
          "palabras" => array:1 [
            0 => "CAPD"
          ]
        ]
      ]
    ]
    "tieneResumen" => true
    "resumen" => array:2 [
      "es" => array:1 [
        "resumen" => "<p class="elsevierStylePara"><span class="elsevierStyleBold">Antecedentes</span><span class="elsevierStyleBold">&#58;</span> Existe informaci&#243;n insuficiente sobre los factores que influyen en las p&#233;rdidas proteicas peritoneales &#40;PPP&#41; durante el tratamiento con di&#225;lisis peritoneal &#40;DP&#41;&#46; En particular&#44; se desconoce el efecto que la modalidad de DP y otras condiciones de prescripci&#243;n pueden tener sobre esta variable&#46; <span class="elsevierStyleBold">M&#233;todo</span><span class="elsevierStyleBold">&#58;</span> Siguiendo un dise&#241;o prospectivo y observacional&#44; analizamos el efecto de las condiciones de prescripci&#243;n de DP sobre las PPP en 24 horas &#40;variable principal&#41; en una cohorte de pacientes incidentes en DP&#46; La estrategia de an&#225;lisis incluy&#243; an&#225;lisis estad&#237;stico mediante modelos mixtos multinivel y estimaciones estandarizadas del transporte proteico peritoneal durante pruebas de equilibrio peritoneal seriadas&#44; con el fin de ajustar para desigualdades en las caracter&#237;sticas de las poblaciones manejadas con diferentes pautas de prescripci&#243;n&#46; <span class="elsevierStyleBold">Resultados</span><span class="elsevierStyleBold">&#58;</span> Estudiamos 284 pacientes&#44; 197 en DP continua ambulatoria &#40;DPCA&#41; y 87 en DP autom&#225;tica &#40;DPA&#41; al inicio de seguimiento&#46; Ambos grupos mostraron diferencias significativas en sus caracter&#237;sticas cl&#237;nicas y de funci&#243;n peritoneal&#46; Las estimaciones seriadas de las PP de 24 horas mostraron valores marginalmente m&#225;s altos en DPCA&#44; permaneciendo esencialmente estables durante el seguimiento&#46; El an&#225;lisis multivariante identific&#243; a la DPCA &#40;B &#61; 888&#44;5 mg&#44; intervalo de confianza 95&#37;&#58; 327&#44;5&#47;1448&#44;6&#41;&#44; el volumen total de dializado infundido &#40;B &#61; 275&#44;9 mg&#47;l&#44; 153&#44;9&#47;397&#44;9&#41; y la ultrafiltraci&#243;n diaria &#40;B &#61; 0&#44;41 mg&#47;ml&#44; 0&#44;02&#47;0&#44;80&#41; como predictores independientes de las PPP de 24 horas&#46; El modelo tambi&#233;n mostr&#243; tendencia a disminuci&#243;n en las PPP con el tiempo en DP&#46; <span class="elsevierStyleBold">Conclusiones</span><span class="elsevierStyleBold">&#58;</span> Las caracter&#237;sticas individuales de transporte peritoneal de prote&#237;nas son el principal determinante de las PPP en 24 horas&#46; La pauta de cambios largos &#40;DPCA&#41; asocia mayores PPP que la de cambios cortos &#40;DPA&#41;&#44; aunque esta diferencia se compensa en la pr&#225;ctica por la correlaci&#243;n positiva entre PPP y volumen infundido&#46; Ultrafiltraci&#243;n y tiempo en di&#225;lisis son predictores secundarios de PPP en 24 horas&#46;</p>"
      ]
      "en" => array:1 [
        "resumen" => "<p class="elsevierStylePara"><span class="elsevierStyleBold">Background&#58;</span> There is a deficit of information regarding the factors that influence peritoneal protein excretion &#40;PPE&#41; during PD therapy&#46; In particular&#44; the effects of the modality of PD and other conditions of the dialysis prescription remain unclear&#46; <span class="elsevierStyleBold">Method&#58;</span> This prospective&#44; observational study analysed the effects of prescription characteristics on 24-hour PPE &#40;study variable&#41; in a cohort of patients starting PD&#46; Our statistical analysis included a multi-level mixed model and standardised estimations of peritoneal protein transport during serial four-hour peritoneal equilibrium tests in order to control for disparities in the characteristics of patients managed on different regimens&#46; <span class="elsevierStyleBold">Results&#58;</span> We evaluated 284 patients&#44; 197 on CAPD and 87 on automated PD &#40;APD&#41;&#44; at the start of PD treatment&#46; The two groups differed in terms of clinical characteristics and peritoneal function&#46; Univariate&#44; serial estimates of 24-hour PPE were marginally higher in CAPD patients&#44; and remained essentially stable over time in both groups&#46; Multivariate analyses identified CAPD &#40;B&#61;888&#46;5mg&#44; 95&#37; CI&#58; 327&#46;5&#47;1448&#46;6&#41;&#44; total dialysate volume infused per day &#40;B&#61;275&#46;9mg&#47;Ll&#59; 153&#46;9&#47;397&#46;9&#41; and ultrafiltration &#40;B&#61;0&#46;41mg&#47;mL&#59; 0&#46;02&#47;0&#46;80&#41; as independent predictors of 24-hour PPE&#46; The model also revealed a minor trend for a lower 24-hour PPE as time on PD increases&#46; <span class="elsevierStyleBold">Conclusions&#58;</span> The individual characteristics of peritoneal protein transport are the major determinants of 24-hour PPE&#46; The use of CAPD as the dialysis modality is associated with higher PPE rates than the APD technique&#44; although this difference is counterbalanced by a direct correlation between PPE and the volume of dialysate infused per day&#46; Ultrafiltration and time on dialysis also act as minor independent predictors of PPE during PD therapy&#46;</p>"
      ]
    ]
    "multimedia" => array:5 [
      0 => array:8 [
        "identificador" => "fig1"
        "etiqueta" => "Tab.  3"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "copyright" => "Elsevier Espa&#241;a"
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "11465_16025_29133_en_t311465.jpg"
            "Alto" => 937
            "Ancho" => 2183
            "Tamanyo" => 872635
          ]
        ]
        "descripcion" => array:1 [
          "en" => "Univariate correlations between treatment prescription and optimisation and 24-hour peritoneal equilibrium test"
        ]
      ]
      1 => array:8 [
        "identificador" => "fig2"
        "etiqueta" => "Tab.  1"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "copyright" => "Elsevier Espa&#241;a"
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "11465_16025_38388_en_t111465.jpg"
            "Alto" => 1249
            "Ancho" => 2168
            "Tamanyo" => 741296
          ]
        ]
        "descripcion" => array:1 [
          "en" => "General characteristics of the study groups at the start of peritoneal dialysis"
        ]
      ]
      2 => array:8 [
        "identificador" => "fig3"
        "etiqueta" => "Tab.  2"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "copyright" => "Elsevier Espa&#241;a"
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "11465_16025_38389_en_t211465.jpg"
            "Alto" => 1564
            "Ancho" => 2155
            "Tamanyo" => 1196441
          ]
        ]
        "descripcion" => array:1 [
          "en" => "Variables for treatment prescription and optimisation"
        ]
      ]
      3 => array:8 [
        "identificador" => "fig4"
        "etiqueta" => "Tab.  4"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "copyright" => "Elsevier Espa&#241;a"
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "11465_16025_38391_en_t411465.jpg"
            "Alto" => 837
            "Ancho" => 2181
            "Tamanyo" => 611303
          ]
        ]
        "descripcion" => array:1 [
          "en" => "Predictors for 24-hour peritoneal protein excretion&#46; Multi-level mixed model&#46; Best model"
        ]
      ]
      4 => array:8 [
        "identificador" => "fig5"
        "etiqueta" => "Fig. 1"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "copyright" => "Elsevier Espa&#241;a"
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "11465_16025_38392_en_f111465.jpg"
            "Alto" => 1003
            "Ancho" => 1016
            "Tamanyo" => 156353
          ]
        ]
        "descripcion" => array:1 [
          "en" => "Peritoneal protein excretion in 24 hours in patients treated with continuous ambulatory peritoneal dialysis or automated peritoneal dialysis during the follow-up period &#40;according to treatment type&#41;"
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/20132514/0000003200000006/v0_201502091602/X2013251412002272/v0_201502091603/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "35441"
    "tipo" => "SECCION"
    "en" => array:2 [
      "titulo" => "Originals"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "en"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/20132514/0000003200000006/v0_201502091602/X2013251412002272/v0_201502091603/en/P1-E544-S3760-A11465-EN.pdf?idApp=UINPBA000064&text.app=https://revistanefrologia.com/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251412002272?idApp=UINPBA000064"
]
Article information
ISSN: 20132514
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2024 November 8 8 16
2024 October 26 39 65
2024 September 37 37 74
2024 August 51 68 119
2024 July 32 28 60
2024 June 47 32 79
2024 May 51 30 81
2024 April 44 33 77
2024 March 33 37 70
2024 February 34 48 82
2024 January 33 27 60
2023 December 15 25 40
2023 November 33 36 69
2023 October 60 33 93
2023 September 82 34 116
2023 August 69 18 87
2023 July 59 27 86
2023 June 38 19 57
2023 May 55 32 87
2023 April 49 28 77
2023 March 66 26 92
2023 February 39 19 58
2023 January 37 28 65
2022 December 51 34 85
2022 November 50 32 82
2022 October 72 51 123
2022 September 33 32 65
2022 August 38 47 85
2022 July 30 42 72
2022 June 41 44 85
2022 May 24 33 57
2022 April 27 53 80
2022 March 50 54 104
2022 February 27 55 82
2022 January 60 32 92
2021 December 41 51 92
2021 November 32 35 67
2021 October 66 51 117
2021 September 43 42 85
2021 August 31 35 66
2021 July 72 43 115
2021 June 61 23 84
2021 May 54 29 83
2021 April 117 38 155
2021 March 55 35 90
2021 February 39 23 62
2021 January 31 25 56
2020 December 32 18 50
2020 November 29 20 49
2020 October 20 18 38
2020 September 33 6 39
2020 August 39 12 51
2020 July 34 9 43
2020 June 27 11 38
2020 May 33 11 44
2020 April 26 18 44
2020 March 37 12 49
2020 February 47 21 68
2020 January 41 26 67
2019 December 58 24 82
2019 November 45 19 64
2019 October 13 8 21
2019 September 30 15 45
2019 August 17 8 25
2019 July 30 23 53
2019 June 32 8 40
2019 May 25 22 47
2019 April 77 33 110
2019 March 32 18 50
2019 February 19 19 38
2019 January 31 19 50
2018 December 77 40 117
2018 November 98 15 113
2018 October 152 21 173
2018 September 76 19 95
2018 August 58 21 79
2018 July 46 18 64
2018 June 63 12 75
2018 May 54 15 69
2018 April 45 9 54
2018 March 53 10 63
2018 February 62 11 73
2018 January 49 6 55
2017 December 61 12 73
2017 November 59 16 75
2017 October 55 12 67
2017 September 45 15 60
2017 August 43 11 54
2017 July 53 18 71
2017 June 42 9 51
2017 May 75 12 87
2017 April 45 19 64
2017 March 64 8 72
2017 February 134 18 152
2017 January 46 15 61
2016 December 96 10 106
2016 November 87 12 99
2016 October 171 15 186
2016 September 275 12 287
2016 August 290 9 299
2016 July 179 16 195
2016 June 152 0 152
2016 May 160 0 160
2016 April 130 0 130
2016 March 119 0 119
2016 February 136 0 136
2016 January 101 0 101
2015 December 151 0 151
2015 November 112 0 112
2015 October 128 0 128
2015 September 96 0 96
2015 August 80 0 80
2015 July 98 0 98
2015 June 45 0 45
2015 May 58 0 58
2015 April 5 0 5
Show all

Follow this link to access the full text of the article

Idiomas
Nefrología (English Edition)
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?